,Hcluster,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,category,subcategory
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,C1,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,12/56,200/4383,5.562255707608492e-06,0.00013209831764922334,0.00010522767835500012,FBLN1/FLNA/FSTL1/IGFBP2/ITGB1/MMP2/PVR/SPP1/TGFBI/TIMP1/TNC/VCAM1,12,,
HALLMARK_COAGULATION,C1,HALLMARK_COAGULATION,HALLMARK_COAGULATION,10/56,138/4383,7.140449602660721e-06,0.00013209831764922334,0.00010522767835500012,C1QA/C2/C9/CFB/GP1BA/MBL2/MMP2/SERPING1/TIMP1/VWF,10,,
HALLMARK_COMPLEMENT,C1,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,10/56,200/4383,0.0001767396403750971,0.002179788897959531,0.0017363894492992,C1QA/C2/C9/CFB/CP/CTSD/GP1BA/S100A9/SERPING1/TIMP1,10,,
HALLMARK_APICAL_JUNCTION,C1,HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,9/56,200/4383,0.0008385294457049149,0.007689802483162976,0.006125589460272072,CDH1/ICAM1/ICAM2/ITGB1/MMP2/TGFBI/VCAM1/VCL/VWF,9,,
HALLMARK_ANGIOGENESIS,C1,HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,4/56,36/4383,0.0010391624977247264,0.007689802483162976,0.006125589460272072,FSTL1/NRP1/SPP1/TIMP1,4,,
HALLMARK_XENOBIOTIC_METABOLISM,C1,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,8/56,200/4383,0.0035115398312948894,0.021654495626318486,0.017249669346711738,APOE/CFB/CRP/FAH/FBLN1/GSTO1/MAN1A1/MBL2,8,,
hsa04610,C1,hsa04610,Complement and coagulation cascades,11/66,88/8843,3.4326381983953916e-11,4.668387949817733e-09,3.7578355014012706e-09,C1QA/C2/C4BPA/C7/C9/CFB/CFHR5/MASP1/MBL2/SERPING1/VWF,11,Organismal Systems,Immune system
hsa05150,C1,hsa05150,Staphylococcus aureus infection,8/66,100/8843,6.743561766608697e-07,4.5856220012939144e-05,3.691212756459498e-05,C1QA/C2/CFB/FCGR3A/ICAM1/KRT10/MASP1/MBL2,8,Human Diseases,Infectious disease: bacterial
hsa05133,C1,hsa05133,Pertussis,6/66,78/8843,2.3130728826946295e-05,0.0010485930401548987,0.0008440687010534788,C1QA/C2/C4BPA/CD14/ITGB1/SERPING1,6,Human Diseases,Infectious disease: bacterial
hsa04512,C1,hsa04512,ECM-receptor interaction,6/66,89/8843,4.908452308691883e-05,0.0016688737849552403,0.0013433658950104102,GP1BA/HSPG2/ITGB1/SPP1/TNC/VWF,6,Environmental Information Processing,Signaling molecules and interaction
hsa05171,C1,hsa05171,Coronavirus disease - COVID-19,9/66,238/8843,6.189735415345219e-05,0.0016836080329738995,0.001355226280412427,C1QA/C2/C7/C9/CFB/MASP1/MBL2/NRP1/VWF,9,Human Diseases,Infectious disease: viral
hsa00010,C1,hsa00010,Glycolysis / Gluconeogenesis,5/66,67/8843,0.00013420402611917515,0.0030419579253679703,0.0024486348625253006,ALDOA/ENO1/GAPDH/PGK1/PKM,5,Metabolism,Carbohydrate metabolism
hsa04514,C1,hsa04514,Cell adhesion molecules,7/66,157/8843,0.00015736088510187645,0.0030572971962650277,0.002460982263247391,ALCAM/CDH1/ICAM1/ICAM2/ITGB1/PVR/VCAM1,7,Environmental Information Processing,Signaling molecules and interaction
hsa01200,C1,hsa01200,Carbon metabolism,6/66,116/8843,0.00021419326522283106,0.0034615949152511693,0.0027864231515953687,ALDOA/ENO1/GAPDH/H6PD/PGK1/PKM,6,Metabolism,Global and overview maps
hsa01230,C1,hsa01230,Biosynthesis of amino acids,5/66,75/8843,0.00022907613409750387,0.0034615949152511693,0.0027864231515953687,ALDOA/ENO1/GAPDH/PGK1/PKM,5,Metabolism,Global and overview maps
hsa04510,C1,hsa04510,Focal adhesion,7/66,203/8843,0.0007491982032197372,0.010189095563788426,0.008201748751037123,FLNA/FLT4/ITGB1/SPP1/TNC/VCL/VWF,7,Cellular Processes,Cellular community - eukaryotes
hsa04145,C1,hsa04145,Phagosome,6/66,157/8843,0.0010742075887172147,0.01328111200595829,0.010690678394889026,CD14/COLEC11/FCGR3A/ITGB1/MBL2/MRC1,6,Cellular Processes,Transport and catabolism
hsa04066,C1,hsa04066,HIF-1 signaling pathway,5/66,109/8843,0.0012762004224687155,0.014463604787978777,0.011642530169890036,ALDOA/ENO1/GAPDH/PGK1/TIMP1,5,Environmental Information Processing,Signal transduction
hsa04820,C1,hsa04820,Cytoskeleton in muscle cells,7/66,232/8843,0.0016314975864781716,0.016352247162126077,0.013162799573228422,DSG2/ENO1/FBLN1/HSPG2/ITGB1/NID1/VCL,7,,
hsa04670,C1,hsa04670,Leukocyte transendothelial migration,5/66,116/8843,0.0016833195608070963,0.016352247162126077,0.013162799573228422,ICAM1/ITGB1/MMP2/VCAM1/VCL,5,Organismal Systems,Immune system
hsa05322,C1,hsa05322,Systemic lupus erythematosus,5/66,139/8843,0.003700642745818641,0.033552494228755676,0.027008199688781664,C1QA/C2/C7/C9/FCGR3A,5,Human Diseases,Immune disease
hsa04936,C1,hsa04936,Alcoholic liver disease,5/66,144/8843,0.004302757291752121,0.03657343697989303,0.029439918311988195,ADIPOQ/C1QA/C2/CD14/LBP,5,Human Diseases,Endocrine and metabolic disease
hsa05417,C1,hsa05417,Lipid and atherosclerosis,6/66,216/8843,0.0053152353793431955,0.042521883034745564,0.034228141142519646,CD14/HSPA8/ICAM1/LBP/SOD2/VCAM1,6,Human Diseases,Cardiovascular disease
R-HSA-166658,C1,R-HSA-166658,Complement cascade,12/78,58/11009,4.5595426106457476e-15,1.4408154649640563e-12,1.1134883007050668e-12,C1QA/C2/C4BPA/C7/C9/CFB/CFHR5/COLEC11/CRP/MASP1/MBL2/SERPING1,12,,
R-HSA-166663,C1,R-HSA-166663,Initial triggering of complement,7/78,23/11009,1.5241913623879685e-10,2.4082223525729903e-08,1.86111787407373e-08,C1QA/C2/CFB/COLEC11/CRP/MASP1/MBL2,7,,
R-HSA-977606,C1,R-HSA-977606,Regulation of Complement cascade,8/78,47/11009,1.1071349434670615e-09,1.1661821404519714e-07,9.012466908223098e-08,C1QA/C2/C4BPA/C7/C9/CFB/CFHR5/SERPING1,8,,
R-HSA-1474244,C1,R-HSA-1474244,Extracellular matrix organization,15/78,300/11009,2.2270815171340875e-09,1.759394398535929e-07,1.3596918736187061e-07,CDH1/CTSD/EFEMP1/FBLN1/HSPG2/ICAM1/ICAM2/ITGB1/MMP2/NID1/SPP1/TIMP1/TNC/VCAM1/VWF,15,,
R-HSA-216083,C1,R-HSA-216083,Integrin cell surface interactions,9/78,85/11009,7.481303344240466e-09,4.728183713559975e-07,3.6540260544500803e-07,CDH1/HSPG2/ICAM1/ICAM2/ITGB1/SPP1/TNC/VCAM1/VWF,9,,
R-HSA-381426,C1,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),10/78,125/11009,1.624333051421624e-08,8.554820737487219e-07,6.611320489996786e-07,APOE/CP/CST3/FSTL1/IGFBP2/IGFBP7/MMP2/SPP1/TIMP1/TNC,10,,
R-HSA-114608,C1,R-HSA-114608,Platelet degranulation,10/78,129/11009,2.2016428069718022e-08,9.938844671472709e-07,7.680919266427942e-07,ALDOA/FLNA/ITIH3/LGALS3BP/SERPINA3/SERPING1/TIMP1/TMSB4X/VCL/VWF,10,,
R-HSA-166786,C1,R-HSA-166786,Creation of C4 and C2 activators,5/78,14/11009,2.986414855884125e-08,1.1142813129417497e-06,8.6113679081441e-07,C1QA/COLEC11/CRP/MASP1/MBL2,5,,
R-HSA-76005,C1,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,10/78,134/11009,3.173586017872072e-08,1.1142813129417497e-06,8.6113679081441e-07,ALDOA/FLNA/ITIH3/LGALS3BP/SERPINA3/SERPING1/TIMP1/TMSB4X/VCL/VWF,10,,
R-HSA-6785807,C1,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,9/78,108/11009,6.237815123452419e-08,1.9711495790109644e-06,1.5233401143589066e-06,HSPA8/ICAM1/ITGB1/LBP/LCN2/MMP2/SAA1/TIMP1/VCAM1,9,,
R-HSA-8957275,C1,R-HSA-8957275,Post-translational protein phosphorylation,8/78,108/11009,8.76736747061787e-07,2.518625564286588e-05,1.9464394767304748e-05,APOE/CP/CST3/FSTL1/IGFBP7/SPP1/TIMP1/TNC,8,,
R-HSA-6798695,C1,R-HSA-6798695,Neutrophil degranulation,15/78,480/11009,1.0892115879380757e-06,2.8682571815702658e-05,2.2166411263301193e-05,ALDOA/CD14/CD93/CST3/CTSD/GGH/HSPA8/LCN2/LRG1/LYZ/PKM/S100A8/S100A9/SERPINA3/VCL,15,,
R-HSA-76002,C1,R-HSA-76002,"Platelet activation, signaling and aggregation",11/78,263/11009,2.214239556501603e-06,5.382305383496204e-05,4.159543134480744e-05,ALDOA/FLNA/GP1BA/ITIH3/LGALS3BP/SERPINA3/SERPING1/TIMP1/TMSB4X/VCL/VWF,11,,
R-HSA-5686938,C1,R-HSA-5686938,Regulation of TLR by endogenous ligand,4/78,21/11009,1.2734877962744591e-05,0.0002874443883019494,0.0002221422321320861,CD14/LBP/S100A8/S100A9,4,,
R-HSA-198933,C1,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,7/78,133/11009,4.151097755606464e-05,0.000874497927181095,0.0006758278451232981,CDH1/FCGR3A/ICAM1/ICAM2/ITGB1/PVR/VCAM1,7,,
R-HSA-1474228,C1,R-HSA-1474228,Degradation of the extracellular matrix,7/78,140/11009,5.7605322509027305e-05,0.0011377051195532893,0.000879239133032522,CDH1/CTSD/HSPG2/MMP2/NID1/SPP1/TIMP1,7,,
R-HSA-430116,C1,R-HSA-430116,GP1b-IX-V activation signalling,3/78,12/11009,7.189362312285774e-05,0.001336375582754297,0.0010327752671518884,FLNA/GP1BA/VWF,3,,
R-HSA-70263,C1,R-HSA-70263,Gluconeogenesis,4/78,35/11009,0.00010333643667156389,0.0018141285549007884,0.001401991421508937,ALDOA/ENO1/GAPDH/PGK1,4,,
R-HSA-977225,C1,R-HSA-977225,Amyloid fiber formation,6/78,110/11009,0.0001242898331707345,0.002067136172734321,0.001597520293385618,APOE/CST3/HSPG2/LYZ/SAA1/TGFBI,6,,
R-HSA-75892,C1,R-HSA-75892,Platelet Adhesion to exposed collagen,3/78,15/11009,0.00014642707592211218,0.0023135477995693725,0.0017879516638910542,GP1BA/ITGB1/VWF,3,,
R-HSA-70171,C1,R-HSA-70171,Glycolysis,5/78,73/11009,0.00016172827222813067,0.0024336254297185377,0.0018807498324273843,ALDOA/ENO1/GAPDH/PGK1/PKM,5,,
R-HSA-9651496,C1,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),3/78,16/11009,0.0001792998868555836,0.002463424532450627,0.0019037791190158078,GP1BA/SERPING1/VWF,3,,
R-HSA-9671793,C1,R-HSA-9671793,Diseases of hemostasis,3/78,16/11009,0.0001792998868555836,0.002463424532450627,0.0019037791190158078,GP1BA/SERPING1/VWF,3,,
R-HSA-2173782,C1,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,4/78,42/11009,0.00021275973257268632,0.002737981984246971,0.0021159620930889314,APOE/COLEC11/MASP1/SAA1,4,,
R-HSA-5602498,C1,R-HSA-5602498,MyD88 deficiency (TLR2/4),3/78,17/11009,0.00021661249875371604,0.002737981984246971,0.0021159620930889314,CD14/S100A8/S100A9,3,,
R-HSA-5603041,C1,R-HSA-5603041,IRAK4 deficiency (TLR2/4),3/78,18/11009,0.0002586115909999699,0.0031431254906150187,0.002429064336517936,CD14/S100A8/S100A9,3,,
R-HSA-3000480,C1,R-HSA-3000480,Scavenging by Class A Receptors,3/78,19/11009,0.0003055381538541344,0.003575928022885425,0.002763541976380475,APOE/COLEC11/MASP1,3,,
R-HSA-449147,C1,R-HSA-449147,Signaling by Interleukins,11/78,473/11009,0.0004708139420342993,0.00531347163152995,0.0041063471636074225,GSTO1/HSPA8/ICAM1/ITGB1/LBP/LCN2/MMP2/SAA1/SOD2/TIMP1/VCAM1,11,,
R-HSA-70326,C1,R-HSA-70326,Glucose metabolism,5/78,93/11009,0.0005012515581583973,0.0054619135302777086,0.004221065752912819,ALDOA/ENO1/GAPDH/PGK1/PKM,5,,
R-HSA-140837,C1,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/78,23/11009,0.0005471442246527193,0.005763252499675311,0.004453945969102839,GP1BA/SERPING1/VWF,3,,
R-HSA-9635486,C1,R-HSA-9635486,Infection with Mycobacterium tuberculosis,3/78,27/11009,0.0008854431682361651,0.009025807779439619,0.006975307810892711,ENO1/MRC1/PGK1,3,,
R-HSA-3000157,C1,R-HSA-3000157,Laminin interactions,3/78,30/11009,0.0012104061405748348,0.011952760638176494,0.009237310020176371,HSPG2/ITGB1/NID1,3,,
R-HSA-5260271,C1,R-HSA-5260271,Diseases of Immune System,3/78,31/11009,0.00133329463095749,0.012391797158310791,0.009576605398827792,CD14/S100A8/S100A9,3,,
R-HSA-5602358,C1,R-HSA-5602358,Diseases associated with the TLR signaling cascade,3/78,31/11009,0.00133329463095749,0.012391797158310791,0.009576605398827792,CD14/S100A8/S100A9,3,,
R-HSA-9824439,C1,R-HSA-9824439,Bacterial Infection Pathways,4/78,73/11009,0.0017528229372309222,0.015825487090427755,0.012230223201130045,CDH1/ENO1/MRC1/PGK1,4,,
R-HSA-8964058,C1,R-HSA-8964058,HDL remodeling,2/78,10/11009,0.0021495149665345264,0.018867964706247513,0.014581505036140648,APOE/PLTP,2,,
R-HSA-2129379,C1,R-HSA-2129379,Molecules associated with elastic fibres,3/78,37/11009,0.002235521631821998,0.019092563125831116,0.01475507876479953,EFEMP1/FBLN1/ITGB1,3,,
R-HSA-140877,C1,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),3/78,39/11009,0.002602847841078331,0.02118934976833498,0.016375513478526702,GP1BA/SERPING1/VWF,3,,
R-HSA-351906,C1,R-HSA-351906,Apoptotic cleavage of cell adhesion  proteins,2/78,11/11009,0.0026151412688767855,0.02118934976833498,0.016375513478526702,CDH1/DSG2,2,,
R-HSA-1566948,C1,R-HSA-1566948,Elastic fibre formation,3/78,44/11009,0.003677571635184745,0.028675118013367862,0.022160650829784623,EFEMP1/FBLN1/ITGB1,3,,
R-HSA-166016,C1,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,5/78,146/11009,0.003720505818190134,0.028675118013367862,0.022160650829784623,CD14/LBP/S100A8/S100A9/SAA1,5,,
R-HSA-6803157,C1,R-HSA-6803157,Antimicrobial peptides,4/78,95/11009,0.004560201776257368,0.034310089554698296,0.0265154589496669,LCN2/LYZ/S100A8/S100A9,4,,
R-HSA-71387,C1,R-HSA-71387,Metabolism of carbohydrates,7/78,299/11009,0.005171873904317105,0.03800725938986524,0.02937269879563203,ALDOA/ENO1/GAPDH/HSPG2/LYVE1/PGK1/PKM,7,,
R-HSA-1236975,C1,R-HSA-1236975,Antigen processing-Cross presentation,4/78,105/11009,0.0064933575384958815,0.04663411323101588,0.03603968777346997,CD14/MRC1/S100A8/S100A9,4,,
R-HSA-168898,C1,R-HSA-168898,Toll-like Receptor Cascades,5/78,168/11009,0.0067172252561280114,0.04716984846525448,0.036453713670683015,CD14/LBP/S100A8/S100A9/SAA1,5,,
R-HSA-446353,C1,R-HSA-446353,Cell-extracellular matrix interactions,2/78,18/11009,0.007045057016396359,0.04839647863437499,0.03740167569345435,FLNA/ITGB1,2,,
GO:0006956,C1,GO:0006956,complement activation,11/87,67/18870,1.0840027895880082e-14,2.3371100143517456e-11,1.7332634077728258e-11,C1QA/C2/C4BPA/C7/C9/CFB/CFHR5/COLEC11/MASP1/MBL2/SERPING1,11,,
GO:0006959,C1,GO:0006959,humoral immune response,14/87,258/18870,1.2473814887155393e-11,1.3446772448353513e-08,9.972486743994232e-09,C1QA/C2/C4BPA/C7/C9/CFB/CFHR5/COLEC11/GAPDH/LYZ/MASP1/MBL2/S100A9/SERPING1,14,,
GO:0006958,C1,GO:0006958,"complement activation, classical pathway",7/87,42/18870,8.197610580281394e-10,5.891349470362228e-07,4.369182621560505e-07,C1QA/C2/C4BPA/C7/C9/MBL2/SERPING1,7,,
GO:0002455,C1,GO:0002455,humoral immune response mediated by circulating immunoglobulin,7/87,55/18870,5.875358809055847e-09,3.1668183980811012e-06,2.348597376567324e-06,C1QA/C2/C4BPA/C7/C9/MBL2/SERPING1,7,,
GO:0008228,C1,GO:0008228,opsonization,5/87,17/18870,1.0985238005283836e-08,4.73683462787839e-06,3.5129634800055055e-06,C4BPA/COLEC11/CRP/LBP/MBL2,5,,
GO:0016049,C1,GO:0016049,cell growth,14/87,497/18870,5.995942417520081e-08,2.103221891253874e-05,1.5598057088246435e-05,ALCAM/APOE/CDH1/ENO1/IGFBP7/ITGB1/MEGF8/NRP1/OLFM1/S100A8/S100A9/SPP1/TNC/VCL,14,,
GO:0042060,C1,GO:0042060,wound healing,13/87,423/18870,6.828642504071019e-08,2.103221891253874e-05,1.5598057088246435e-05,ANXA6/APOE/FBLN1/FGL1/FLNA/GP1BA/ITGB1/LRG1/SAA1/SERPING1/TIMP1/VCL/VWF,13,,
GO:0048675,C1,GO:0048675,axon extension,8/87,121/18870,8.664267893072702e-08,2.335020197183093e-05,1.731713543365452e-05,ALCAM/APOE/CDH1/ITGB1/MEGF8/NRP1/OLFM1/VCL,8,,
GO:0001867,C1,GO:0001867,"complement activation, lectin pathway",4/87,11/18870,1.3569540188290196e-07,2.9905952043578903e-05,2.217905534332407e-05,COLEC11/MASP1/MBL2/SERPING1,4,,
GO:0006909,C1,GO:0006909,phagocytosis,10/87,237/18870,1.387103527067667e-07,2.9905952043578903e-05,2.217905534332407e-05,ADIPOQ/C2/C4BPA/CD14/CD93/COLEC11/CRP/ITGB1/LBP/MBL2,10,,
GO:0060560,C1,GO:0060560,developmental growth involved in morphogenesis,10/87,244/18870,1.818066813791008e-07,3.5634109550303756e-05,2.6427210432043464e-05,ALCAM/APOE/CDH1/ITGB1/MEGF8/NRP1/OLFM1/SPP1/TNC/VCL,10,,
GO:0006910,C1,GO:0006910,"phagocytosis, recognition",5/87,29/18870,2.018455097046749e-07,3.626490991027326e-05,2.689502888082467e-05,C4BPA/COLEC11/CRP/LBP/MBL2,5,,
GO:0044403,C1,GO:0044403,biological process involved in symbiotic interaction,11/87,322/18870,2.660136600096056e-07,4.411734238313151e-05,3.271860320280089e-05,APOE/CFHR5/GAPDH/HSPA8/ICAM1/ITGB1/MBL2/MRC1/NRP1/PVR/SLC3A2,11,,
GO:0007566,C1,GO:0007566,embryo implantation,6/87,60/18870,3.3070863364056723e-07,5.092912958064735e-05,3.777040710526479e-05,FBLN1/HSPG2/IGFBP7/MMP2/SPP1/TIMP1,6,,
GO:0008037,C1,GO:0008037,cell recognition,8/87,154/18870,5.553065525545025e-07,7.98160618205005e-05,5.9193730058265923e-05,ALDOA/C4BPA/COLEC11/CRP/LBP/MBL2/MEGF8/NRP1,8,,
GO:0001906,C1,GO:0001906,cell killing,9/87,223/18870,8.826297162920666e-07,0.00011618923885051795,8.616905273603007e-05,C7/C9/CFHR5/FCGR3A/GAPDH/ICAM1/LYZ/MBL2/PVR,9,,
GO:0007596,C1,GO:0007596,blood coagulation,9/87,224/18870,9.161489148695757e-07,0.00011618923885051795,8.616905273603007e-05,APOE/FBLN1/FGL1/FLNA/GP1BA/SAA1/SERPING1/VCL/VWF,9,,
GO:0050817,C1,GO:0050817,coagulation,9/87,229/18870,1.1007943187343518e-06,0.00013185069728840346,9.778400995072987e-05,APOE/FBLN1/FGL1/FLNA/GP1BA/SAA1/SERPING1/VCL/VWF,9,,
GO:0007599,C1,GO:0007599,hemostasis,9/87,231/18870,1.1831957369724757e-06,0.00013233781641497526,9.814527054699124e-05,APOE/FBLN1/FGL1/FLNA/GP1BA/SAA1/SERPING1/VCL/VWF,9,,
GO:0006957,C1,GO:0006957,"complement activation, alternative pathway",4/87,18/18870,1.2276235288958745e-06,0.00013233781641497526,9.814527054699124e-05,C7/C9/CFB/CFHR5,4,,
GO:0048588,C1,GO:0048588,developmental cell growth,9/87,239/18870,1.5684645563018523e-06,0.0001610290277803235,0.00011942344165526386,ALCAM/APOE/CDH1/ITGB1/MEGF8/NRP1/OLFM1/SPP1/VCL,9,,
GO:1990138,C1,GO:1990138,neuron projection extension,8/87,179/18870,1.7301349510362835e-06,0.00016955322520155578,0.00012574521486239784,ALCAM/APOE/CDH1/ITGB1/MEGF8/NRP1/OLFM1/VCL,8,,
GO:0007565,C1,GO:0007565,female pregnancy,8/87,186/18870,2.304907960941974e-06,0.00021606006799090855,0.00016023593559134366,DSG2/FBLN1/HSPG2/IGFBP2/IGFBP7/MMP2/SPP1/TIMP1,8,,
GO:0097305,C1,GO:0097305,response to alcohol,9/87,254/18870,2.5883253304520878e-06,0.00022528874646154956,0.00016708017082076645,ADIPOQ/CD14/CDH1/H6PD/IGFBP7/S100A8/SOD2/TNC/VCAM1,9,,
GO:0030168,C1,GO:0030168,platelet activation,7/87,133/18870,2.6959967897119835e-06,0.00022528874646154956,0.00016708017082076645,APOE/FGL1/FLNA/GP1BA/SAA1/VCL/VWF,7,,
GO:0006953,C1,GO:0006953,acute-phase response,5/87,48/18870,2.7168401706865903e-06,0.00022528874646154956,0.00016708017082076645,CRP/LBP/MBL2/SAA1/SERPINA3,5,,
GO:0001558,C1,GO:0001558,regulation of cell growth,11/87,417/18870,3.337569668256066e-06,0.0002665111186948177,0.0001976517865918505,APOE/CDH1/ENO1/IGFBP7/MEGF8/NRP1/OLFM1/S100A8/S100A9/SPP1/TNC,11,,
GO:0031640,C1,GO:0031640,killing of cells of another organism,6/87,92/18870,4.18722755303996e-06,0.0003112987104949708,0.00023086746472115066,C7/C9/CFHR5/GAPDH/LYZ/MBL2,6,,
GO:0141061,C1,GO:0141061,disruption of cell in another organism,6/87,92/18870,4.18722755303996e-06,0.0003112987104949708,0.00023086746472115066,C7/C9/CFHR5/GAPDH/LYZ/MBL2,6,,
GO:0016064,C1,GO:0016064,immunoglobulin mediated immune response,8/87,205/18870,4.742825588264871e-06,0.0003408510656099687,0.00025278428310787155,C1QA/C2/C4BPA/C7/C9/FCGR3A/MBL2/SERPING1,8,,
GO:0044703,C1,GO:0044703,multi-organism reproductive process,8/87,206/18870,4.916093985711314e-06,0.0003419064075223739,0.00025356695294721516,DSG2/FBLN1/HSPG2/IGFBP2/IGFBP7/MMP2/SPP1/TIMP1,8,,
GO:0019724,C1,GO:0019724,B cell mediated immunity,8/87,208/18870,5.278770773232469e-06,0.0003556571808465376,0.0002637648948861882,C1QA/C2/C4BPA/C7/C9/FCGR3A/MBL2/SERPING1,8,,
GO:0031589,C1,GO:0031589,cell-substrate adhesion,10/87,356/18870,5.5507456911683824e-06,0.00036264871848966764,0.0002689500065353995,FBLN1/FGL1/FLNA/ITGB1/LYVE1/NID1/NRP1/VCAM1/VCL/VWF,10,,
GO:0141060,C1,GO:0141060,disruption of anatomical structure in another organism,6/87,99/18870,6.412726266239311e-06,0.00040664228911799867,0.00030157681728846793,C7/C9/CFHR5/GAPDH/LYZ/MBL2,6,,
GO:0044706,C1,GO:0044706,multi-multicellular organism process,8/87,216/18870,6.965020690397699e-06,0.00042125450320218893,0.000312413626776743,DSG2/FBLN1/HSPG2/IGFBP2/IGFBP7/MMP2/SPP1/TIMP1,8,,
GO:0052548,C1,GO:0052548,regulation of endopeptidase activity,9/87,288/18870,7.1831135750182736e-06,0.00042125450320218893,0.000312413626776743,CST3/CTSD/GAPDH/S100A8/S100A9/SERPINA11/SERPINA3/SERPING1/TIMP1,9,,
GO:0007584,C1,GO:0007584,response to nutrient,7/87,155/18870,7.424554226161139e-06,0.00042125450320218893,0.000312413626776743,ADIPOQ/C2/IGFBP2/SOD2/SPP1/TNC/VCAM1,7,,
GO:0002449,C1,GO:0002449,lymphocyte mediated immunity,10/87,368/18870,7.424708312469007e-06,0.00042125450320218893,0.000312413626776743,C1QA/C2/C4BPA/C7/C9/FCGR3A/ICAM1/MBL2/PVR/SERPING1,10,,
GO:0002460,C1,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,10/87,380/18870,9.823558674146911e-06,0.0005413231053432321,0.0004014597192736889,C1QA/C2/C4BPA/C7/C9/FCGR3A/ICAM1/MBL2/PVR/SERPING1,10,,
GO:0002526,C1,GO:0002526,acute inflammatory response,6/87,107/18870,1.0043100284661079e-05,0.0005413231053432321,0.0004014597192736889,CRP/FCGR3A/LBP/MBL2/SAA1/SERPINA3,6,,
GO:0061387,C1,GO:0061387,regulation of extent of cell growth,6/87,109/18870,1.117092245082926e-05,0.0005874270439997044,0.0004356516355021732,APOE/CDH1/MEGF8/NRP1/OLFM1/SPP1,6,,
GO:0007162,C1,GO:0007162,negative regulation of cell adhesion,9/87,312/18870,1.3629839618582211e-05,0.0006707840933356593,0.0004974714567800345,ADIPOQ/CDH1/FBLN1/FGL1/HSPG2/MMP2/PODXL/TGFBI/TNC,9,,
GO:0052547,C1,GO:0052547,regulation of peptidase activity,9/87,312/18870,1.3629839618582211e-05,0.0006707840933356593,0.0004974714567800345,CST3/CTSD/GAPDH/S100A8/S100A9/SERPINA11/SERPINA3/SERPING1/TIMP1,9,,
GO:0051651,C1,GO:0051651,maintenance of location in cell,8/87,237/18870,1.3689471292564476e-05,0.0006707840933356593,0.0004974714567800345,ANXA6/APOE/FLNA/GP1BA/GSTO1/S100A8/S100A9/TMSB4X,8,,
GO:0050900,C1,GO:0050900,leukocyte migration,10/87,396/18870,1.4045211808743803e-05,0.0006729217035478142,0.0004990567657890489,GP1BA/ICAM1/ITGB1/LBP/LYVE1/MMP2/S100A8/S100A9/SAA1/VCAM1,10,,
GO:1903027,C1,GO:1903027,regulation of opsonization,3/87,11/18870,1.5207592170508972e-05,0.0007127732330351596,0.0005286117278490419,C4BPA/COLEC11/MBL2,3,,
GO:0001667,C1,GO:0001667,ameboidal-type cell migration,11/87,497/18870,1.743957616799298e-05,0.0007999941748551673,0.0005932971153232102,ANXA6/APOE/FLT4/FSTL1/ITGB1/LRG1/MEGF8/NRP1/S100A9/TIMP1/TMSB4X,11,,
GO:0045471,C1,GO:0045471,response to ethanol,6/87,121/18870,2.0287164404548136e-05,0.0009112318011709537,0.0006757939195286978,ADIPOQ/CD14/S100A8/SOD2/TNC/VCAM1,6,,
GO:0045123,C1,GO:0045123,cellular extravasation,5/87,74/18870,2.326535012781955e-05,0.0010236754056240603,0.0007591851094341118,GP1BA/ICAM1/ITGB1/LYVE1/VCAM1,5,,
GO:0005996,C1,GO:0005996,monosaccharide metabolic process,8/87,261/18870,2.738393959688193e-05,0.0011568706623631226,0.0008579662806999236,ADIPOQ/ALDOA/ENO1/GAPDH/GSTO1/H6PD/PGK1/PKM,8,,
GO:0090504,C1,GO:0090504,epiboly,4/87,38/18870,2.7601931661631776e-05,0.0011568706623631226,0.0008579662806999236,FLNA/ITGB1/LRG1/MEGF8,4,,
GO:0010951,C1,GO:0010951,negative regulation of endopeptidase activity,6/87,128/18870,2.7902260873322068e-05,0.0011568706623631226,0.0008579662806999236,CST3/GAPDH/SERPINA11/SERPINA3/SERPING1/TIMP1,6,,
GO:0051235,C1,GO:0051235,maintenance of location,9/87,350/18870,3.3697250221453705e-05,0.001370778707121777,0.0010166062182003612,ANXA6/APOE/CRP/FLNA/GP1BA/GSTO1/S100A8/S100A9/TMSB4X,9,,
GO:0010466,C1,GO:0010466,negative regulation of peptidase activity,6/87,137/18870,4.090659645815923e-05,0.001633233740070209,0.0012112499029228827,CST3/GAPDH/SERPINA11/SERPINA3/SERPING1/TIMP1,6,,
GO:0048678,C1,GO:0048678,response to axon injury,5/87,84/18870,4.3005563450535536e-05,0.001685818087260993,0.0012502478637581528,FLNA/MMP2/SOD2/SPP1/TNC,5,,
GO:0098742,C1,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,8/87,279/18870,4.396846873816677e-05,0.0016927860464194206,0.0012554154889713408,ADIPOQ/ALCAM/CDH1/DSG2/ICAM1/ITGB1/PVR/VCAM1,8,,
GO:0050878,C1,GO:0050878,regulation of body fluid levels,9/87,365/18870,4.668166421906472e-05,0.001765713474671992,0.0013095004237998029,APOE/FBLN1/FGL1/FLNA/GP1BA/SAA1/SERPING1/VCL/VWF,9,,
GO:0017014,C1,GO:0017014,protein nitrosylation,3/87,16/18870,5.0759197082978036e-05,0.0018239471485150106,0.0013526880766498886,GAPDH/S100A8/S100A9,3,,
GO:0018119,C1,GO:0018119,peptidyl-cysteine S-nitrosylation,3/87,16/18870,5.0759197082978036e-05,0.0018239471485150106,0.0013526880766498886,GAPDH/S100A8/S100A9,3,,
GO:0072378,C1,GO:0072378,"blood coagulation, fibrin clot formation",3/87,16/18870,5.0759197082978036e-05,0.0018239471485150106,0.0013526880766498886,FBLN1/FLNA/GP1BA,3,,
GO:0002443,C1,GO:0002443,leukocyte mediated immunity,10/87,466/18870,5.601546673915542e-05,0.0019747168381254645,0.0014645029182270193,C1QA/C2/C4BPA/C7/C9/FCGR3A/ICAM1/MBL2/PVR/SERPING1,10,,
GO:0006096,C1,GO:0006096,glycolytic process,5/87,89/18870,5.6786847849619113e-05,0.0019747168381254645,0.0014645029182270193,ALDOA/ENO1/GAPDH/PGK1/PKM,5,,
GO:0030516,C1,GO:0030516,regulation of axon extension,5/87,92/18870,6.655491816861853e-05,0.0022776571995482783,0.001689171607320494,APOE/CDH1/MEGF8/NRP1/OLFM1,5,,
GO:0001666,C1,GO:0001666,response to hypoxia,8/87,298/18870,6.98435766810482e-05,0.0023528554894428114,0.0017449406739886882,ADIPOQ/ENO1/HSPG2/MMP2/PGK1/SOD2/VASN/VCAM1,8,,
GO:0006735,C1,GO:0006735,NADH regeneration,3/87,18/18870,7.347148603659445e-05,0.00236424662529698,0.0017533886455551768,ENO1/PGK1/PKM,3,,
GO:0061621,C1,GO:0061621,canonical glycolysis,3/87,18/18870,7.347148603659445e-05,0.00236424662529698,0.0017533886455551768,ENO1/PGK1/PKM,3,,
GO:0061718,C1,GO:0061718,glucose catabolic process to pyruvate,3/87,18/18870,7.347148603659445e-05,0.00236424662529698,0.0017533886455551768,ENO1/PGK1/PKM,3,,
GO:0046718,C1,GO:0046718,viral entry into host cell,6/87,156/18870,8.431101545487891e-05,0.0026405489674450606,0.0019583018658085377,ICAM1/ITGB1/MRC1/NRP1/PVR/SLC3A2,6,,
GO:0002523,C1,GO:0002523,leukocyte migration involved in inflammatory response,3/87,19/18870,8.695685375166943e-05,0.0026405489674450606,0.0019583018658085377,LBP/S100A8/S100A9,3,,
GO:0002544,C1,GO:0002544,chronic inflammatory response,3/87,19/18870,8.695685375166943e-05,0.0026405489674450606,0.0019583018658085377,S100A8/S100A9/VCAM1,3,,
GO:0072376,C1,GO:0072376,protein activation cascade,3/87,19/18870,8.695685375166943e-05,0.0026405489674450606,0.0019583018658085377,FBLN1/FLNA/GP1BA,3,,
GO:0031667,C1,GO:0031667,response to nutrient levels,10/87,495/18870,9.24464992718066e-05,0.002768259061527986,0.0020530150934776935,ADIPOQ/APOE/C2/H6PD/HSPA8/IGFBP2/SOD2/SPP1/TNC/VCAM1,10,,
GO:0031103,C1,GO:0031103,axon regeneration,4/87,52/18870,9.637806253527129e-05,0.002846453463370478,0.0021110061570450917,FLNA/MMP2/SPP1/TNC,4,,
GO:0019318,C1,GO:0019318,hexose metabolic process,7/87,233/18870,0.00010103275995933218,0.0029086577552584086,0.0021571385266270495,ADIPOQ/ALDOA/ENO1/GAPDH/H6PD/PGK1/PKM,7,,
GO:0061620,C1,GO:0061620,glycolytic process through glucose-6-phosphate,3/87,20/18870,0.00010196157505610127,0.0029086577552584086,0.0021571385266270495,ENO1/PGK1/PKM,3,,
GO:0036293,C1,GO:0036293,response to decreased oxygen levels,8/87,315/18870,0.00010271202065416021,0.0029086577552584086,0.0021571385266270495,ADIPOQ/ENO1/HSPG2/MMP2/PGK1/SOD2/VASN/VCAM1,8,,
GO:0007157,C1,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,4/87,53/18870,0.00010388063411637173,0.0029086577552584086,0.0021571385266270495,ALCAM/ICAM1/PVR/VCAM1,4,,
GO:0044409,C1,GO:0044409,entry into host,6/87,163/18870,0.00010738664923498524,0.0029682771250080535,0.0022013538486901833,ICAM1/ITGB1/MRC1/NRP1/PVR/SLC3A2,6,,
GO:0032677,C1,GO:0032677,regulation of interleukin-8 production,5/87,103/18870,0.00011386614828367731,0.00309597365178493,0.002296057014481647,ADIPOQ/CD14/CRP/LBP/TMSB4X,5,,
GO:0019058,C1,GO:0019058,viral life cycle,8/87,321/18870,0.00011700547580824019,0.00309597365178493,0.002296057014481647,APOE/HSPA8/ICAM1/ITGB1/MRC1/NRP1/PVR/SLC3A2,8,,
GO:0007160,C1,GO:0007160,cell-matrix adhesion,7/87,239/18870,0.00011833385681764034,0.00309597365178493,0.002296057014481647,FGL1/ITGB1/LYVE1/NID1/NRP1/VCAM1/VCL,7,,
GO:2001044,C1,GO:2001044,regulation of integrin-mediated signaling pathway,3/87,21/18870,0.00011855919368262456,0.00309597365178493,0.002296057014481647,FLNA/NID1/TIMP1,3,,
GO:0032637,C1,GO:0032637,interleukin-8 production,5/87,104/18870,0.00011918636971157198,0.00309597365178493,0.002296057014481647,ADIPOQ/CD14/CRP/LBP/TMSB4X,5,,
GO:0060326,C1,GO:0060326,cell chemotaxis,8/87,325/18870,0.00012741995073326792,0.003270445402153877,0.002425449939396416,LBP/MMP2/NRP1/S100A8/S100A9/SAA1/TMSB4X/VCAM1,8,,
GO:0007159,C1,GO:0007159,leukocyte cell-cell adhesion,9/87,419/18870,0.00013379171847704004,0.003393587588664686,0.0025167754844163943,FGL1/GP1BA/ICAM1/IGFBP2/ITGB1/LRG1/S100A8/S100A9/VCAM1,9,,
GO:0031102,C1,GO:0031102,neuron projection regeneration,4/87,58/18870,0.00014789529287261135,0.0036451016343675056,0.0027033050398419306,FLNA/MMP2/SPP1/TNC,4,,
GO:0061756,C1,GO:0061756,leukocyte adhesion to vascular endothelial cell,4/87,58/18870,0.00014789529287261135,0.0036451016343675056,0.0027033050398419306,GP1BA/ITGB1/LRG1/VCAM1,4,,
GO:1903034,C1,GO:1903034,regulation of response to wounding,6/87,173/18870,0.00014877965854561247,0.0036451016343675056,0.0027033050398419306,APOE/FLNA/GP1BA/ITGB1/SERPING1/SPP1,6,,
GO:0007229,C1,GO:0007229,integrin-mediated signaling pathway,5/87,111/18870,0.00016196602496294815,0.003923581458652991,0.0029098331391924103,FLNA/ITGB1/NID1/NRP1/TIMP1,5,,
GO:0016032,C1,GO:0016032,viral process,9/87,432/18870,0.00016823066713290592,0.003999168314218583,0.00296589037657359,APOE/HSPA8/ICAM1/ITGB1/MBL2/MRC1/NRP1/PVR/SLC3A2,9,,
GO:0002011,C1,GO:0002011,morphogenesis of an epithelial sheet,4/87,60/18870,0.0001687960652105246,0.003999168314218583,0.00296589037657359,FLNA/ITGB1/LRG1/MEGF8,4,,
GO:0061615,C1,GO:0061615,glycolytic process through fructose-6-phosphate,3/87,24/18870,0.0001786287882244994,0.0041731219068932065,0.003094899021858599,ENO1/PGK1/PKM,3,,
GO:0034113,C1,GO:0034113,heterotypic cell-cell adhesion,4/87,61/18870,0.0001800094329040205,0.0041731219068932065,0.003094899021858599,ADIPOQ/DSG2/ITGB1/VCAM1,4,,
GO:0070482,C1,GO:0070482,response to oxygen levels,8/87,343/18870,0.00018425128084957084,0.004226018739485901,0.0031341287302407406,ADIPOQ/ENO1/HSPG2/MMP2/PGK1/SOD2/VASN/VCAM1,8,,
GO:0006898,C1,GO:0006898,receptor-mediated endocytosis,7/87,258/18870,0.00018966141959714586,0.004304316006857331,0.003192196081640605,ADIPOQ/APOE/CD14/HSPG2/ITGB1/LYVE1/MRC1,7,,
GO:0032496,C1,GO:0032496,response to lipopolysaccharide,8/87,348/18870,0.00020329394335476063,0.004565643144508999,0.0033860032889899278,C2/CD14/LBP/MRC1/S100A8/S100A9/SOD2/VCAM1,8,,
GO:0048771,C1,GO:0048771,tissue remodeling,6/87,184/18870,0.00020795469796931832,0.0046221683383695904,0.0034279238873075922,CST3/FLNA/FLT4/MMP2/SPP1/TIMP1,6,,
GO:0006090,C1,GO:0006090,pyruvate metabolic process,5/87,118/18870,0.00021559955665313612,0.004743190246368995,0.003517676976972222,ALDOA/ENO1/GAPDH/PGK1/PKM,5,,
GO:0007409,C1,GO:0007409,axonogenesis,9/87,448/18870,0.00022049956928125796,0.004801990619902951,0.003561284909497404,ALCAM/APOE/CDH1/ITGB1/MEGF8/NRP1/OLFM1/SPP1/VCL,9,,
GO:0008361,C1,GO:0008361,regulation of cell size,6/87,187/18870,0.00022694396413075823,0.004892911866659147,0.003628714542259177,APOE/CDH1/MEGF8/NRP1/OLFM1/SPP1,6,,
GO:0044000,C1,GO:0044000,movement in host,6/87,188/18870,0.000233568613238275,0.004985880496452683,0.0036976625691395497,ICAM1/ITGB1/MRC1/NRP1/PVR/SLC3A2,6,,
GO:0051702,C1,GO:0051702,biological process involved in interaction with symbiont,5/87,121/18870,0.0002423301465765794,0.0051221940786186785,0.0037987563740951927,APOE/CFHR5/GAPDH/HSPA8/MBL2,5,,
GO:0006007,C1,GO:0006007,glucose catabolic process,3/87,27/18870,0.00025557983623643516,0.005298366605055328,0.003929410640112804,ENO1/PGK1/PKM,3,,
GO:0010875,C1,GO:0010875,positive regulation of cholesterol efflux,3/87,27/18870,0.00025557983623643516,0.005298366605055328,0.003929410640112804,ADIPOQ/APOE/PLTP,3,,
GO:0006006,C1,GO:0006006,glucose metabolic process,6/87,193/18870,0.0002690138125713464,0.0055237502847983126,0.004096561215998749,ADIPOQ/ENO1/GAPDH/H6PD/PGK1/PKM,6,,
GO:0051873,C1,GO:0051873,killing by host of symbiont cells,3/87,28/18870,0.0002852977905417752,0.0058028494000761065,0.004303548598142568,CFHR5/GAPDH/MBL2,3,,
GO:0002237,C1,GO:0002237,response to molecule of bacterial origin,8/87,369/18870,0.00030183643456106773,0.006061731046068856,0.004495542163352502,C2/CD14/LBP/MRC1/S100A8/S100A9/SOD2/VCAM1,8,,
GO:0006935,C1,GO:0006935,chemotaxis,9/87,468/18870,0.00030421918379147937,0.006061731046068856,0.004495542163352502,LBP/MEGF8/MMP2/NRP1/S100A8/S100A9/SAA1/TMSB4X/VCAM1,9,,
GO:0002752,C1,GO:0002752,cell surface pattern recognition receptor signaling pathway,4/87,70/18870,0.0003064604285814032,0.006061731046068856,0.004495542163352502,CD14/COLEC11/LBP/MBL2,4,,
GO:0042330,C1,GO:0042330,taxis,9/87,470/18870,0.0003138734023188519,0.006151918685449498,0.004562427733228096,LBP/MEGF8/MMP2/NRP1/S100A8/S100A9/SAA1/TMSB4X/VCAM1,9,,
GO:0010631,C1,GO:0010631,epithelial cell migration,8/87,372/18870,0.0003186580936356102,0.006189431079985365,0.004590247930132688,APOE/FLT4/FSTL1/ITGB1/LRG1/NRP1/S100A9/TMSB4X,8,,
GO:0090132,C1,GO:0090132,epithelium migration,8/87,375/18870,0.0003362390482401331,0.0064726016786225615,0.004800254833428216,APOE/FLT4/FSTL1/ITGB1/LRG1/NRP1/S100A9/TMSB4X,8,,
GO:0043542,C1,GO:0043542,endothelial cell migration,7/87,284/18870,0.00033992826471413476,0.006485710962156412,0.00480997702935045,APOE/FLT4/FSTL1/ITGB1/NRP1/S100A9/TMSB4X,7,,
GO:0090130,C1,GO:0090130,tissue migration,8/87,380/18870,0.00036729823296426605,0.006946447283078576,0.00515167143003435,APOE/FLT4/FSTL1/ITGB1/LRG1/NRP1/S100A9/TMSB4X,8,,
GO:0051701,C1,GO:0051701,biological process involved in interaction with host,6/87,211/18870,0.0004329581169272354,0.008117023479087996,0.006019802101715979,ICAM1/ITGB1/MRC1/NRP1/PVR/SLC3A2,6,,
GO:0010977,C1,GO:0010977,negative regulation of neuron projection development,5/87,140/18870,0.00047468594191495844,0.00882261112731595,0.0065430848073395826,APOE/CDH1/FLNA/NRP1/SPP1,5,,
GO:0050901,C1,GO:0050901,leukocyte tethering or rolling,3/87,34/18870,0.0005108278709656225,0.009400367055289386,0.006971564084066292,GP1BA/ITGB1/VCAM1,3,,
GO:0051346,C1,GO:0051346,negative regulation of hydrolase activity,6/87,218/18870,0.000514491332339586,0.009400367055289386,0.006971564084066292,CST3/GAPDH/SERPINA11/SERPINA3/SERPING1/TIMP1,6,,
GO:0044319,C1,GO:0044319,"wound healing, spreading of cells",3/87,37/18870,0.0006567074392074072,0.011798843657759748,0.008750338597860102,FLNA/ITGB1/LRG1,3,,
GO:0090505,C1,GO:0090505,epiboly involved in wound healing,3/87,37/18870,0.0006567074392074072,0.011798843657759748,0.008750338597860102,FLNA/ITGB1/LRG1,3,,
GO:0032370,C1,GO:0032370,positive regulation of lipid transport,4/87,86/18870,0.0006711413961266045,0.011958519421892225,0.008868758422934428,ADIPOQ/APOE/PLTP/SPP1,4,,
GO:0032373,C1,GO:0032373,positive regulation of sterol transport,3/87,38/18870,0.0007106307684256157,0.01225695949380502,0.009090089576745352,ADIPOQ/APOE/PLTP,3,,
GO:0032376,C1,GO:0032376,positive regulation of cholesterol transport,3/87,38/18870,0.0007106307684256157,0.01225695949380502,0.009090089576745352,ADIPOQ/APOE/PLTP,3,,
GO:0048846,C1,GO:0048846,axon extension involved in axon guidance,3/87,38/18870,0.0007106307684256157,0.01225695949380502,0.009090089576745352,ALCAM/MEGF8/NRP1,3,,
GO:1902284,C1,GO:1902284,neuron projection extension involved in neuron projection guidance,3/87,38/18870,0.0007106307684256157,0.01225695949380502,0.009090089576745352,ALCAM/MEGF8/NRP1,3,,
GO:0045807,C1,GO:0045807,positive regulation of endocytosis,5/87,155/18870,0.000753477246538062,0.012813170960105648,0.009502590903427633,APOE/C2/CD14/COLEC11/MBL2,5,,
GO:0045861,C1,GO:0045861,negative regulation of proteolysis,6/87,235/18870,0.0007625204448651718,0.012813170960105648,0.009502590903427633,CST3/GAPDH/SERPINA11/SERPINA3/SERPING1/TIMP1,6,,
GO:0045088,C1,GO:0045088,regulation of innate immune response,8/87,425/18870,0.0007666507670935197,0.012813170960105648,0.009502590903427633,APOE/CD14/COLEC11/HSPA8/LBP/MBL2/PVR/SERPING1,8,,
GO:0050727,C1,GO:0050727,regulation of inflammatory response,8/87,425/18870,0.0007666507670935197,0.012813170960105648,0.009502590903427633,ADIPOQ/APOE/LBP/S100A8/S100A9/SAA1/TMSB4X/TNC,8,,
GO:0042742,C1,GO:0042742,defense response to bacterium,7/87,330/18870,0.0008288360284360867,0.013661155054287829,0.010131478628778057,CRP/LBP/LCN2/LYZ/MBL2/S100A8/S100A9,7,,
GO:0002220,C1,GO:0002220,innate immune response activating cell surface receptor signaling pathway,4/87,91/18870,0.0008300609054321455,0.013661155054287829,0.010131478628778057,CD14/COLEC11/LBP/MBL2,4,,
GO:0002691,C1,GO:0002691,regulation of cellular extravasation,3/87,41/18870,0.0008890697668810799,0.014521472859057638,0.010769513364372893,GP1BA/ICAM1/LYVE1,3,,
GO:0010572,C1,GO:0010572,positive regulation of platelet activation,2/87,10/18870,0.0009231483253179585,0.01463461609842293,0.01085342342227538,FLNA/GP1BA,2,,
GO:0014012,C1,GO:0014012,peripheral nervous system axon regeneration,2/87,10/18870,0.0009231483253179585,0.01463461609842293,0.01085342342227538,MMP2/TNC,2,,
GO:0070391,C1,GO:0070391,response to lipoteichoic acid,2/87,10/18870,0.0009231483253179585,0.01463461609842293,0.01085342342227538,CD14/LBP,2,,
GO:0071223,C1,GO:0071223,cellular response to lipoteichoic acid,2/87,10/18870,0.0009231483253179585,0.01463461609842293,0.01085342342227538,CD14/LBP,2,,
GO:0016052,C1,GO:0016052,carbohydrate catabolic process,5/87,163/18870,0.0009446518496054735,0.014866199910579568,0.01102517218248724,ALDOA/ENO1/GAPDH/PGK1/PKM,5,,
GO:0034109,C1,GO:0034109,homotypic cell-cell adhesion,4/87,96/18870,0.0010138589896018626,0.015839710011460985,0.01174715335778207,DSG2/FGL1/FLNA/VCL,4,,
GO:0014002,C1,GO:0014002,astrocyte development,3/87,43/18870,0.0010224556919660821,0.01585909691999189,0.011761531208606431,C1QA/S100A8/S100A9,3,,
GO:1903035,C1,GO:1903035,negative regulation of response to wounding,4/87,97/18870,0.0010537815325361995,0.01622823560105747,0.01203529434528186,APOE/GP1BA/SERPING1/SPP1,4,,
GO:0019320,C1,GO:0019320,hexose catabolic process,3/87,44/18870,0.0010936326895813744,0.016722497012322292,0.012401851851243807,ENO1/PGK1/PKM,3,,
GO:0071492,C1,GO:0071492,cellular response to UV-A,2/87,11/18870,0.0011249129326840598,0.01684244640879745,0.012490809537624905,MMP2/TIMP1,2,,
GO:0072015,C1,GO:0072015,podocyte development,2/87,11/18870,0.0011249129326840598,0.01684244640879745,0.012490809537624905,ADIPOQ/PODXL,2,,
GO:2001171,C1,GO:2001171,positive regulation of ATP biosynthetic process,2/87,11/18870,0.0011249129326840598,0.01684244640879745,0.012490809537624905,ENO1/TMSB4X,2,,
GO:0098869,C1,GO:0098869,cellular oxidant detoxification,4/87,99/18870,0.0011369187088808858,0.016904805078256483,0.012537056397750025,APOE/GSTO1/S100A9/SOD2,4,,
GO:0018198,C1,GO:0018198,peptidyl-cysteine modification,3/87,45/18870,0.0011678663592396671,0.01701297209811299,0.012617275957930687,GAPDH/S100A8/S100A9,3,,
GO:0030574,C1,GO:0030574,collagen catabolic process,3/87,45/18870,0.0011678663592396671,0.01701297209811299,0.012617275957930687,CST3/ITGB1/MMP2,3,,
GO:0051602,C1,GO:0051602,response to electrical stimulus,3/87,45/18870,0.0011678663592396671,0.01701297209811299,0.012617275957930687,CD14/MMP2/SOD2,3,,
GO:0050764,C1,GO:0050764,regulation of phagocytosis,4/87,100/18870,0.0011801656171098545,0.01707675886234125,0.012664581931401405,ADIPOQ/C2/COLEC11/MBL2,4,,
GO:0048762,C1,GO:0048762,mesenchymal cell differentiation,6/87,262/18870,0.001335757086546121,0.018720390585915327,0.013883543257497015,ANXA6/FLNA/LRG1/NRP1/OLFM1/VASN,6,,
GO:0051238,C1,GO:0051238,sequestering of metal ion,2/87,12/18870,0.0013458536831247104,0.018720390585915327,0.013883543257497015,S100A8/S100A9,2,,
GO:0060312,C1,GO:0060312,regulation of blood vessel remodeling,2/87,12/18870,0.0013458536831247104,0.018720390585915327,0.013883543257497015,CST3/FLT4,2,,
GO:0072310,C1,GO:0072310,glomerular epithelial cell development,2/87,12/18870,0.0013458536831247104,0.018720390585915327,0.013883543257497015,ADIPOQ/PODXL,2,,
GO:1903580,C1,GO:1903580,positive regulation of ATP metabolic process,2/87,12/18870,0.0013458536831247104,0.018720390585915327,0.013883543257497015,ENO1/TMSB4X,2,,
GO:2001046,C1,GO:2001046,positive regulation of integrin-mediated signaling pathway,2/87,12/18870,0.0013458536831247104,0.018720390585915327,0.013883543257497015,FLNA/NID1,2,,
GO:0030195,C1,GO:0030195,negative regulation of blood coagulation,3/87,48/18870,0.0014093972278638477,0.019478592456887538,0.014445846080466836,APOE/GP1BA/SERPING1,3,,
GO:0032526,C1,GO:0032526,response to retinoic acid,4/87,106/18870,0.001464158587471622,0.02010653448782686,0.014911544715852456,IGFBP2/IGFBP7/MMP2/TNC,4,,
GO:0010543,C1,GO:0010543,regulation of platelet activation,3/87,49/18870,0.0014963431816231957,0.020272203690283146,0.015034409435377455,APOE/FLNA/GP1BA,3,,
GO:1900047,C1,GO:1900047,negative regulation of hemostasis,3/87,49/18870,0.0014963431816231957,0.020272203690283146,0.015034409435377455,APOE/GP1BA/SERPING1,3,,
GO:0001936,C1,GO:0001936,regulation of endothelial cell proliferation,5/87,181/18870,0.001504430700577599,0.020272203690283146,0.015034409435377455,APOE/FLT4/HSPG2/LRG1/NRP1,5,,
GO:0030593,C1,GO:0030593,neutrophil chemotaxis,4/87,107/18870,0.0015157260303224995,0.020297548579970865,0.015053205884667388,LBP/S100A8/S100A9/SAA1,4,,
GO:1905952,C1,GO:1905952,regulation of lipid localization,5/87,183/18870,0.0015790176197420802,0.020721035870635493,0.015367275406452162,ADIPOQ/APOE/CRP/PLTP/SPP1,5,,
GO:0034145,C1,GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,2/87,13/18870,0.0015857935615282265,0.020721035870635493,0.015367275406452162,CD14/LBP,2,,
GO:0045916,C1,GO:0045916,negative regulation of complement activation,2/87,13/18870,0.0015857935615282265,0.020721035870635493,0.015367275406452162,C4BPA/SERPING1,2,,
GO:0070486,C1,GO:0070486,leukocyte aggregation,2/87,13/18870,0.0015857935615282265,0.020721035870635493,0.015367275406452162,S100A8/S100A9,2,,
GO:0032535,C1,GO:0032535,regulation of cellular component size,7/87,370/18870,0.0016039583748292273,0.020832134073083215,0.015449668810181333,APOE/CDH1/MEGF8/NRP1/OLFM1/SPP1/TMSB4X,7,,
GO:0031349,C1,GO:0031349,positive regulation of defense response,8/87,480/18870,0.0016670883238876714,0.021171404396696014,0.015701280772669295,CD14/COLEC11/HSPA8/LBP/MBL2/PVR/S100A8/S100A9,8,,
GO:0043086,C1,GO:0043086,negative regulation of catalytic activity,8/87,480/18870,0.0016670883238876714,0.021171404396696014,0.015701280772669295,ADIPOQ/APOE/CST3/GAPDH/SERPINA11/SERPINA3/SERPING1/TIMP1,8,,
GO:0042116,C1,GO:0042116,macrophage activation,4/87,110/18870,0.0016780092131945233,0.021171404396696014,0.015701280772669295,C1QA/CD93/FCGR3A/LBP,4,,
GO:0001974,C1,GO:0001974,blood vessel remodeling,3/87,51/18870,0.001680166113964826,0.021171404396696014,0.015701280772669295,CST3/FLNA/FLT4,3,,
GO:0010043,C1,GO:0010043,response to zinc ion,3/87,51/18870,0.001680166113964826,0.021171404396696014,0.015701280772669295,S100A8/SOD2/VCAM1,3,,
GO:0032102,C1,GO:0032102,negative regulation of response to external stimulus,8/87,481/18870,0.0016889988665267693,0.021171404396696014,0.015701280772669295,ADIPOQ/APOE/GP1BA/HSPA8/NRP1/SAA1/SERPING1/SPP1,8,,
GO:0045785,C1,GO:0045785,positive regulation of cell adhesion,8/87,482/18870,0.0017111374637828218,0.021249875630075393,0.015759477141921944,FLNA/GP1BA/IGFBP2/NID1/NRP1/PODXL/SAA1/VCAM1,8,,
GO:0050808,C1,GO:0050808,synapse organization,8/87,483/18870,0.0017335057987600485,0.021249875630075393,0.015759477141921944,APOE/C1QA/CDH1/FLNA/HSPA8/ITGB1/NRP1/TNC,8,,
GO:0001938,C1,GO:0001938,positive regulation of endothelial cell proliferation,4/87,111/18870,0.0017346837249041136,0.021249875630075393,0.015759477141921944,FLT4/HSPG2/LRG1/NRP1,4,,
GO:1905954,C1,GO:1905954,positive regulation of lipid localization,4/87,111/18870,0.0017346837249041136,0.021249875630075393,0.015759477141921944,ADIPOQ/APOE/PLTP/SPP1,4,,
GO:0006968,C1,GO:0006968,cellular defense response,3/87,52/18870,0.0017771327293584706,0.021405017678753423,0.015874534642137707,ITGB1/LBP/LGALS3BP,3,,
GO:0046365,C1,GO:0046365,monosaccharide catabolic process,3/87,52/18870,0.0017771327293584706,0.021405017678753423,0.015874534642137707,ENO1/PGK1/PKM,3,,
GO:0050819,C1,GO:0050819,negative regulation of coagulation,3/87,52/18870,0.0017771327293584706,0.021405017678753423,0.015874534642137707,APOE/GP1BA/SERPING1,3,,
GO:0001894,C1,GO:0001894,tissue homeostasis,6/87,279/18870,0.0018371607761824135,0.021613393162030824,0.016029071483802768,AZGP1/ITGB1/LYZ/SERPINA3/SPP1/VCL,6,,
GO:0060249,C1,GO:0060249,anatomical structure homeostasis,6/87,279/18870,0.0018371607761824135,0.021613393162030824,0.016029071483802768,AZGP1/ITGB1/LYZ/SERPINA3/SPP1/VCL,6,,
GO:0010745,C1,GO:0010745,negative regulation of macrophage derived foam cell differentiation,2/87,14/18870,0.001844556744811536,0.021613393162030824,0.016029071483802768,ADIPOQ/CRP,2,,
GO:0070141,C1,GO:0070141,response to UV-A,2/87,14/18870,0.001844556744811536,0.021613393162030824,0.016029071483802768,MMP2/TIMP1,2,,
GO:0098883,C1,GO:0098883,synapse pruning,2/87,14/18870,0.001844556744811536,0.021613393162030824,0.016029071483802768,C1QA/ITGB1,2,,
GO:1904645,C1,GO:1904645,response to amyloid-beta,3/87,53/18870,0.0018775278550729984,0.02188081111101289,0.016227395800033486,ICAM1/MMP2/VCAM1,3,,
GO:0031099,C1,GO:0031099,regeneration,5/87,191/18870,0.0019048281346089233,0.022079620743101283,0.016374838350146886,FLNA/HSPG2/MMP2/SPP1/TNC,5,,
GO:0031345,C1,GO:0031345,negative regulation of cell projection organization,5/87,192/18870,0.0019487645321373663,0.022468108723466104,0.01666295144563276,APOE/CDH1/FLNA/NRP1/SPP1,5,,
GO:0010874,C1,GO:0010874,regulation of cholesterol efflux,3/87,54/18870,0.0019813943005906,0.02272279846847518,0.01685183618475432,ADIPOQ/APOE/PLTP,3,,
GO:0042159,C1,GO:0042159,lipoprotein catabolic process,2/87,15/18870,0.0021219685948970185,0.024161046840570456,0.017918479714298663,APOE/CTSD,2,,
GO:0002697,C1,GO:0002697,regulation of immune effector process,7/87,389/18870,0.002129220268881441,0.024161046840570456,0.017918479714298663,C4BPA/COLEC11/ICAM1/LBP/MBL2/PVR/SERPING1,7,,
GO:0050830,C1,GO:0050830,defense response to Gram-positive bacterium,4/87,118/18870,0.002169154668437167,0.024485327042672943,0.01815897460102539,CRP/LBP/LYZ/MBL2,4,,
GO:0050832,C1,GO:0050832,defense response to fungus,3/87,56/18870,0.0021997084480997113,0.02470089278178634,0.018318843929075998,GAPDH/S100A8/S100A9,3,,
GO:1990748,C1,GO:1990748,cellular detoxification,4/87,119/18870,0.002236803652674251,0.024987298835055363,0.018531250332218092,APOE/GSTO1/S100A9/SOD2,4,,
GO:0030100,C1,GO:0030100,regulation of endocytosis,6/87,291/18870,0.002269120584840125,0.02521764938616139,0.018702084472990505,ADIPOQ/APOE/C2/CD14/COLEC11/MBL2,6,,
GO:0030810,C1,GO:0030810,positive regulation of nucleotide biosynthetic process,2/87,16/18870,0.0024178556517275977,0.02639447223785941,0.01957484783190531,ENO1/TMSB4X,2,,
GO:0034375,C1,GO:0034375,high-density lipoprotein particle remodeling,2/87,16/18870,0.0024178556517275977,0.02639447223785941,0.01957484783190531,APOE/PLTP,2,,
GO:1900373,C1,GO:1900373,positive regulation of purine nucleotide biosynthetic process,2/87,16/18870,0.0024178556517275977,0.02639447223785941,0.01957484783190531,ENO1/TMSB4X,2,,
GO:0001935,C1,GO:0001935,endothelial cell proliferation,5/87,202/18870,0.0024299283274544863,0.02639447223785941,0.01957484783190531,APOE/FLT4/HSPG2/LRG1/NRP1,5,,
GO:0021782,C1,GO:0021782,glial cell development,4/87,122/18870,0.0024484668124173854,0.02639447223785941,0.01957484783190531,ADGRG6/C1QA/S100A8/S100A9,4,,
GO:0022612,C1,GO:0022612,gland morphogenesis,4/87,122/18870,0.0024484668124173854,0.02639447223785941,0.01957484783190531,FGL1/MMP2/NRP1/TNC,4,,
GO:0031638,C1,GO:0031638,zymogen activation,3/87,59/18870,0.0025542398032929836,0.027397716497013298,0.02031888065567972,ENO1/MASP1/PGK1,3,,
GO:0045446,C1,GO:0045446,endothelial cell differentiation,4/87,124/18870,0.002596993795081567,0.02771840902077158,0.020556714824017202,FSTL1/ICAM1/NRP1/VCL,4,,
GO:0002921,C1,GO:0002921,negative regulation of humoral immune response,2/87,17/18870,0.0027320456263198985,0.02845550903548648,0.021103367944978014,C4BPA/SERPING1,2,,
GO:0021535,C1,GO:0021535,cell migration in hindbrain,2/87,17/18870,0.0027320456263198985,0.02845550903548648,0.021103367944978014,FLNA/ITGB1,2,,
GO:0032488,C1,GO:0032488,Cdc42 protein signal transduction,2/87,17/18870,0.0027320456263198985,0.02845550903548648,0.021103367944978014,APOE/NRP1,2,,
GO:0033631,C1,GO:0033631,cell-cell adhesion mediated by integrin,2/87,17/18870,0.0027320456263198985,0.02845550903548648,0.021103367944978014,ITGB1/PODXL,2,,
GO:1900120,C1,GO:1900120,regulation of receptor binding,2/87,17/18870,0.0027320456263198985,0.02845550903548648,0.021103367944978014,ADIPOQ/NRP1,2,,
GO:1900024,C1,GO:1900024,regulation of substrate adhesion-dependent cell spreading,3/87,61/18870,0.0028090884413467052,0.029117282113189886,0.02159415659112169,FBLN1/FLNA/NRP1,3,,
GO:0097237,C1,GO:0097237,cellular response to toxic substance,4/87,128/18870,0.0029124037696562854,0.030043744150138524,0.02228124566158599,APOE/GSTO1/S100A9/SOD2,4,,
GO:1990266,C1,GO:1990266,neutrophil migration,4/87,129/18870,0.002995169129160765,0.030750403059383858,0.022805322843083724,LBP/S100A8/S100A9/SAA1,4,,
GO:0002693,C1,GO:0002693,positive regulation of cellular extravasation,2/87,18/18870,0.0030643673938553157,0.03117120319242826,0.023117399496776943,ICAM1/LYVE1,2,,
GO:0032757,C1,GO:0032757,positive regulation of interleukin-8 production,3/87,63/18870,0.003079080345756278,0.03117120319242826,0.023117399496776943,ADIPOQ/CD14/LBP,3,,
GO:0071621,C1,GO:0071621,granulocyte chemotaxis,4/87,130/18870,0.003079529814465315,0.03117120319242826,0.023117399496776943,LBP/S100A8/S100A9/SAA1,4,,
GO:0002064,C1,GO:0002064,epithelial cell development,5/87,214/18870,0.0031151626694578384,0.03138453605304252,0.023275612862304267,ADIPOQ/FLNA/ICAM1/PODXL/VCL,5,,
GO:0070372,C1,GO:0070372,regulation of ERK1 and ERK2 cascade,6/87,313/18870,0.003255074651279792,0.032641585805391775,0.024207874640362323,ADIPOQ/APOE/FBLN1/FLT4/ICAM1/NRP1,6,,
GO:0034764,C1,GO:0034764,positive regulation of transmembrane transport,5/87,217/18870,0.003306251559744955,0.03300128871671353,0.024474639957371282,ADIPOQ/FLNA/GSTO1/ITGB1/TMSB4X,5,,
GO:0019730,C1,GO:0019730,antimicrobial humoral response,4/87,133/18870,0.0033423333556070645,0.033055370250866196,0.0245147482721735,COLEC11/GAPDH/LYZ/S100A9,4,,
GO:0061041,C1,GO:0061041,regulation of wound healing,4/87,133/18870,0.0033423333556070645,0.033055370250866196,0.0245147482721735,APOE/GP1BA/ITGB1/SERPING1,4,,
GO:0040013,C1,GO:0040013,negative regulation of locomotion,7/87,423/18870,0.003392074117266749,0.033394117793731096,0.024765972526451293,ADIPOQ/APOE/CDH1/FBLN1/NRP1/TIMP1/VCL,7,,
GO:2001169,C1,GO:2001169,regulation of ATP biosynthetic process,2/87,19/18870,0.003414650986808684,0.0334635796707251,0.024817487315609527,ENO1/TMSB4X,2,,
GO:0010810,C1,GO:0010810,regulation of cell-substrate adhesion,5/87,220/18870,0.003505656198848333,0.03411803857667567,0.02530285157600349,FBLN1/FLNA/NID1/NRP1/VCL,5,,
GO:0050771,C1,GO:0050771,negative regulation of axonogenesis,3/87,66/18870,0.003513081894258812,0.03411803857667567,0.02530285157600349,CDH1/NRP1/SPP1,3,,
GO:0009620,C1,GO:0009620,response to fungus,3/87,67/18870,0.003665622073730143,0.03543982596844031,0.026283124522049037,GAPDH/S100A8/S100A9,3,,
GO:0030198,C1,GO:0030198,extracellular matrix organization,6/87,321/18870,0.0036830414127872707,0.03544927359807748,0.02629013113733019,CST3/FBLN1/ITGB1/MMP2/NID1/TGFBI,6,,
GO:0046034,C1,GO:0046034,ATP metabolic process,4/87,137/18870,0.0037159744032420326,0.035449738112344344,0.02629047563355682,ALDOA/ENO1/HSPA8/TMSB4X,4,,
GO:0051283,C1,GO:0051283,negative regulation of sequestering of calcium ion,4/87,137/18870,0.0037159744032420326,0.035449738112344344,0.02629047563355682,ANXA6/FLNA/GP1BA/GSTO1,4,,
GO:0043062,C1,GO:0043062,extracellular structure organization,6/87,322/18870,0.00373934360744424,0.035515527831056305,0.026339267051740327,CST3/FBLN1/ITGB1/MMP2/NID1/TGFBI,6,,
GO:0055093,C1,GO:0055093,response to hyperoxia,2/87,20/18870,0.0037827275881145254,0.0357414345534998,0.026506805530107508,MMP2/SOD2,2,,
GO:0045229,C1,GO:0045229,external encapsulating structure organization,6/87,323/18870,0.003796284096823494,0.0357414345534998,0.026506805530107508,CST3/FBLN1/ITGB1/MMP2/NID1/TGFBI,6,,
GO:0030193,C1,GO:0030193,regulation of blood coagulation,3/87,68/18870,0.0038221533756157573,0.03582853338185901,0.026571400354967214,APOE/GP1BA/SERPING1,3,,
GO:0009410,C1,GO:0009410,response to xenobiotic stimulus,7/87,434/18870,0.0039037208639901276,0.036364070866999124,0.02696856930327687,ADIPOQ/CDH1/GSTO1/HSPG2/IGFBP2/MMP2/SOD2,7,,
GO:0051282,C1,GO:0051282,regulation of sequestering of calcium ion,4/87,139/18870,0.003913016902200277,0.036364070866999124,0.02696856930327687,ANXA6/FLNA/GP1BA/GSTO1,4,,
GO:0032835,C1,GO:0032835,glomerulus development,3/87,69/18870,0.00398270753796411,0.03683251661697884,0.02731598122311828,ADIPOQ/NID1/PODXL,3,,
GO:0060485,C1,GO:0060485,mesenchyme development,6/87,327/18870,0.0040305172765020235,0.03683251661697884,0.02731598122311828,ANXA6/FLNA/LRG1/NRP1/OLFM1/VASN,6,,
GO:0048638,C1,GO:0048638,regulation of developmental growth,6/87,328/18870,0.004090715479228638,0.03683251661697884,0.02731598122311828,APOE/CDH1/MEGF8/NRP1/OLFM1/SPP1,6,,
GO:0048662,C1,GO:0048662,negative regulation of smooth muscle cell proliferation,3/87,70/18870,0.00414731561748871,0.03683251661697884,0.02731598122311828,ADIPOQ/APOE/SOD2,3,,
GO:1900046,C1,GO:1900046,regulation of hemostasis,3/87,70/18870,0.00414731561748871,0.03683251661697884,0.02731598122311828,APOE/GP1BA/SERPING1,3,,
GO:0007413,C1,GO:0007413,axonal fasciculation,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,MEGF8/NRP1,2,,
GO:0044794,C1,GO:0044794,positive regulation by host of viral process,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,APOE/HSPA8,2,,
GO:0045981,C1,GO:0045981,positive regulation of nucleotide metabolic process,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,ENO1/TMSB4X,2,,
GO:0061318,C1,GO:0061318,renal filtration cell differentiation,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,ADIPOQ/PODXL,2,,
GO:0072112,C1,GO:0072112,podocyte differentiation,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,ADIPOQ/PODXL,2,,
GO:0106030,C1,GO:0106030,neuron projection fasciculation,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,MEGF8/NRP1,2,,
GO:1900544,C1,GO:1900544,positive regulation of purine nucleotide metabolic process,2/87,21/18870,0.004168429524370518,0.03683251661697884,0.02731598122311828,ENO1/TMSB4X,2,,
GO:0048545,C1,GO:0048545,response to steroid hormone,6/87,330/18870,0.0042131107663553585,0.036999789414324406,0.02744003521158031,ADIPOQ/DSG2/HSPA8/IGFBP2/IGFBP7/SPP1,6,,
GO:0043393,C1,GO:0043393,regulation of protein binding,4/87,142/18870,0.004221682836699353,0.036999789414324406,0.02744003521158031,ADIPOQ/APOE/CFHR5/NRP1,4,,
GO:1902475,C1,GO:1902475,L-alpha-amino acid transmembrane transport,3/87,71/18870,0.004316007996358208,0.03747563006900545,0.027792931390889217,ITGB1/SLC38A10/SLC3A2,3,,
GO:0003158,C1,GO:0003158,endothelium development,4/87,143/18870,0.0043281223966523,0.03747563006900545,0.027792931390889217,FSTL1/ICAM1/NRP1/VCL,4,,
GO:0051208,C1,GO:0051208,sequestering of calcium ion,4/87,143/18870,0.0043281223966523,0.03747563006900545,0.027792931390889217,ANXA6/FLNA/GP1BA/GSTO1,4,,
GO:0014823,C1,GO:0014823,response to activity,3/87,72/18870,0.004488814388934234,0.038202901544854014,0.028332295404078334,ADIPOQ/MMP2/SOD2,3,,
GO:0050766,C1,GO:0050766,positive regulation of phagocytosis,3/87,72/18870,0.004488814388934234,0.038202901544854014,0.028332295404078334,C2/COLEC11/MBL2,3,,
GO:0070527,C1,GO:0070527,platelet aggregation,3/87,72/18870,0.004488814388934234,0.038202901544854014,0.028332295404078334,FGL1/FLNA/VCL,3,,
GO:0050921,C1,GO:0050921,positive regulation of chemotaxis,4/87,145/18870,0.004546412482134402,0.038202901544854014,0.028332295404078334,LBP/MEGF8/NRP1/TMSB4X,4,,
GO:0030449,C1,GO:0030449,regulation of complement activation,2/87,22/18870,0.004571590259078077,0.038202901544854014,0.028332295404078334,C4BPA/SERPING1,2,,
GO:0035313,C1,GO:0035313,"wound healing, spreading of epidermal cells",2/87,22/18870,0.004571590259078077,0.038202901544854014,0.028332295404078334,ITGB1/LRG1,2,,
GO:0051220,C1,GO:0051220,cytoplasmic sequestering of protein,2/87,22/18870,0.004571590259078077,0.038202901544854014,0.028332295404078334,FLNA/TMSB4X,2,,
GO:0072311,C1,GO:0072311,glomerular epithelial cell differentiation,2/87,22/18870,0.004571590259078077,0.038202901544854014,0.028332295404078334,ADIPOQ/PODXL,2,,
GO:0150105,C1,GO:0150105,protein localization to cell-cell junction,2/87,22/18870,0.004571590259078077,0.038202901544854014,0.028332295404078334,FLNA/VCL,2,,
GO:0070371,C1,GO:0070371,ERK1 and ERK2 cascade,6/87,336/18870,0.004596607162832043,0.038248619229178826,0.028366200863745063,ADIPOQ/APOE/FBLN1/FLT4/ICAM1/NRP1,6,,
GO:0035296,C1,GO:0035296,regulation of tube diameter,4/87,146/18870,0.004658290934752173,0.038248619229178826,0.028366200863745063,APOE/CRP/MMP2/SOD2,4,,
GO:0097746,C1,GO:0097746,blood vessel diameter maintenance,4/87,146/18870,0.004658290934752173,0.038248619229178826,0.028366200863745063,APOE/CRP/MMP2/SOD2,4,,
GO:0033344,C1,GO:0033344,cholesterol efflux,3/87,73/18870,0.004665763848457342,0.038248619229178826,0.028366200863745063,ADIPOQ/APOE/PLTP,3,,
GO:0050818,C1,GO:0050818,regulation of coagulation,3/87,73/18870,0.004665763848457342,0.038248619229178826,0.028366200863745063,APOE/GP1BA/SERPING1,3,,
GO:0002221,C1,GO:0002221,pattern recognition receptor signaling pathway,5/87,236/18870,0.004717902052728713,0.038529533430617824,0.028574534362419923,CD14/COLEC11/HSPA8/LBP/MBL2,5,,
GO:0035150,C1,GO:0035150,regulation of tube size,4/87,147/18870,0.0047720101472008706,0.038678398035207055,0.02868493634189997,APOE/CRP/MMP2/SOD2,4,,
GO:0062013,C1,GO:0062013,positive regulation of small molecule metabolic process,4/87,147/18870,0.0047720101472008706,0.038678398035207055,0.02868493634189997,ADIPOQ/APOE/ENO1/TMSB4X,4,,
GO:0010975,C1,GO:0010975,regulation of neuron projection development,7/87,453/18870,0.004923486427070211,0.039756691897990165,0.029484627962624296,APOE/CDH1/FLNA/MEGF8/NRP1/S100A9/SPP1,7,,
GO:0031290,C1,GO:0031290,retinal ganglion cell axon guidance,2/87,23/18870,0.004992044385919856,0.0400105862306439,0.029672922802630647,ALCAM/NRP1,2,,
GO:0035855,C1,GO:0035855,megakaryocyte development,2/87,23/18870,0.004992044385919856,0.0400105862306439,0.029672922802630647,FLNA/GP1BA,2,,
GO:0035924,C1,GO:0035924,cellular response to vascular endothelial growth factor stimulus,3/87,75/18870,0.005032204915457147,0.04003481106171811,0.029690888586441668,FLT4/NRP1/VCAM1,3,,
GO:0061045,C1,GO:0061045,negative regulation of wound healing,3/87,75/18870,0.005032204915457147,0.04003481106171811,0.029690888586441668,APOE/GP1BA/SERPING1,3,,
GO:0030595,C1,GO:0030595,leukocyte chemotaxis,5/87,240/18870,0.0050623844577509505,0.04008701532693308,0.02972960466829965,LBP/MMP2/S100A8/S100A9/SAA1,5,,
GO:0045089,C1,GO:0045089,positive regulation of innate immune response,6/87,343/18870,0.005075953239449318,0.04008701532693308,0.02972960466829965,CD14/COLEC11/HSPA8/LBP/MBL2/PVR,6,,
GO:0097529,C1,GO:0097529,myeloid leukocyte migration,5/87,242/18870,0.005241162960671356,0.04124068373433374,0.03058519607091737,LBP/MMP2/S100A8/S100A9/SAA1,5,,
GO:0051043,C1,GO:0051043,regulation of membrane protein ectodomain proteolysis,2/87,24/18870,0.005429627622073989,0.04241404765649102,0.0314553941950053,APOE/TIMP1,2,,
GO:1903578,C1,GO:1903578,regulation of ATP metabolic process,2/87,24/18870,0.005429627622073989,0.04241404765649102,0.0314553941950053,ENO1/TMSB4X,2,,
GO:0032368,C1,GO:0032368,regulation of lipid transport,4/87,153/18870,0.00549374647929243,0.042759990647489095,0.031711954786415364,ADIPOQ/APOE/PLTP/SPP1,4,,
GO:0045765,C1,GO:0045765,regulation of angiogenesis,6/87,349/18870,0.005515293187538136,0.042773280979612305,0.03172181125282253,HSPG2/ITGB1/LRG1/NRP1/PGK1/PKM,6,,
GO:0006936,C1,GO:0006936,muscle contraction,6/87,351/18870,0.005667758538876913,0.04379816275920654,0.03248189104151682,ALDOA/ANXA6/DSG2/ENO1/FLNA/GSTO1,6,,
GO:0097530,C1,GO:0097530,granulocyte migration,4/87,156/18870,0.005880561258189086,0.044807006765145325,0.033230076787547976,LBP/S100A8/S100A9/SAA1,4,,
GO:0006706,C1,GO:0006706,steroid catabolic process,2/87,25/18870,0.005884176801564736,0.044807006765145325,0.033230076787547976,APOE/SPP1,2,,
GO:0008045,C1,GO:0008045,motor neuron axon guidance,2/87,25/18870,0.005884176801564736,0.044807006765145325,0.033230076787547976,ALCAM/NRP1,2,,
GO:0072010,C1,GO:0072010,glomerular epithelium development,2/87,25/18870,0.005884176801564736,0.044807006765145325,0.033230076787547976,ADIPOQ/PODXL,2,,
GO:1901342,C1,GO:1901342,regulation of vasculature development,6/87,354/18870,0.0059022216703623715,0.044807006765145325,0.033230076787547976,HSPG2/ITGB1/LRG1/NRP1/PGK1/PKM,6,,
GO:0050770,C1,GO:0050770,regulation of axonogenesis,4/87,157/18870,0.006013431451955827,0.045243852447389765,0.03355405325045653,CDH1/MEGF8/NRP1/SPP1,4,,
GO:0032371,C1,GO:0032371,regulation of sterol transport,3/87,80/18870,0.00602272061799669,0.045243852447389765,0.03355405325045653,ADIPOQ/APOE/PLTP,3,,
GO:0032374,C1,GO:0032374,regulation of cholesterol transport,3/87,80/18870,0.00602272061799669,0.045243852447389765,0.03355405325045653,ADIPOQ/APOE/PLTP,3,,
GO:0010976,C1,GO:0010976,positive regulation of neuron projection development,4/87,158/18870,0.006148289210556266,0.045867513972177545,0.03401657734778718,APOE/FLNA/NRP1/S100A9,4,,
GO:0098754,C1,GO:0098754,detoxification,4/87,158/18870,0.006148289210556266,0.045867513972177545,0.03401657734778718,APOE/GSTO1/S100A9/SOD2,4,,
GO:0050810,C1,GO:0050810,regulation of steroid biosynthetic process,3/87,81/18870,0.006233783361104126,0.04634495491910516,0.03437066034670479,APOE/H6PD/IGFBP7,3,,
GO:0060343,C1,GO:0060343,trabecula formation,2/87,26/18870,0.006355529868649634,0.046926446564413055,0.03480191013150251,ADGRG6/MMP2,2,,
GO:0060740,C1,GO:0060740,prostate gland epithelium morphogenesis,2/87,26/18870,0.006355529868649634,0.046926446564413055,0.03480191013150251,MMP2/TNC,2,,
GO:0002758,C1,GO:0002758,innate immune response-activating signaling pathway,5/87,255/18870,0.006513941657853011,0.047931939298058335,0.035547610484205946,CD14/COLEC11/HSPA8/LBP/MBL2,5,,
GO:0009205,C1,GO:0009205,purine ribonucleoside triphosphate metabolic process,4/87,161/18870,0.0065649156732338265,0.04814271493704806,0.03570392734565766,ALDOA/ENO1/HSPA8/TMSB4X,4,,
GO:0035023,C1,GO:0035023,regulation of Rho protein signal transduction,3/87,83/18870,0.006669059266750001,0.048740650098688144,0.03614737208275916,APOE/ITGB1/NRP1,3,,
GO:0042176,C1,GO:0042176,regulation of protein catabolic process,6/87,364/18870,0.00673517628209333,0.04876144210130614,0.03616279198900695,APOE/C4BPA/CDH1/CST3/FLNA/TIMP1,6,,
GO:0009636,C1,GO:0009636,response to toxic substance,5/87,258/18870,0.006835948458020193,0.04876144210130614,0.03616279198900695,APOE/CDH1/GSTO1/S100A9/SOD2,5,,
GO:0031639,C1,GO:0031639,plasminogen activation,2/87,27/18870,0.006843525871242695,0.04876144210130614,0.03616279198900695,ENO1/PGK1,2,,
GO:0036296,C1,GO:0036296,response to increased oxygen levels,2/87,27/18870,0.006843525871242695,0.04876144210130614,0.03616279198900695,MMP2/SOD2,2,,
GO:0042730,C1,GO:0042730,fibrinolysis,2/87,27/18870,0.006843525871242695,0.04876144210130614,0.03616279198900695,GP1BA/SERPING1,2,,
GO:0060384,C1,GO:0060384,innervation,2/87,27/18870,0.006843525871242695,0.04876144210130614,0.03616279198900695,NRP1/VCAM1,2,,
GO:0150146,C1,GO:0150146,cell junction disassembly,2/87,27/18870,0.006843525871242695,0.04876144210130614,0.03616279198900695,C1QA/ITGB1,2,,
GO:0030307,C1,GO:0030307,positive regulation of cell growth,4/87,163/18870,0.006852837178430315,0.04876144210130614,0.03616279198900695,MEGF8/NRP1/S100A8/S100A9,4,,
HALLMARK_COAGULATION,C2,HALLMARK_COAGULATION,HALLMARK_COAGULATION,10/24,138/4383,9.31392109836743e-10,1.4902273757387888e-08,1.274536571355543e-08,C1R/C1S/C3/C8A/C8B/C8G/ITIH1/MASP2/PROS1/THBS1,10,,
HALLMARK_XENOBIOTIC_METABOLISM,C2,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,6/24,200/4383,0.0005651407817900697,0.004521126254320558,0.0038667527175110035,FETUB/ITIH1/ITIH4/LCAT/PROS1/PTGDS,6,,
hsa04610,C2,hsa04610,Complement and coagulation cascades,12/25,88/8843,2.0319279578919566e-18,1.686500205050324e-16,1.390266497505023e-16,C1QB/C1R/C1S/C3/C5/C8A/C8B/C8G/MASP2/PROS1/SERPIND1/SERPINF2,12,Organismal Systems,Immune system
hsa05322,C2,hsa05322,Systemic lupus erythematosus,8/25,139/8843,2.628763851724947e-09,1.090936998465853e-07,8.99313949274324e-08,C1QB/C1R/C1S/C3/C5/C8A/C8B/C8G,8,Human Diseases,Immune disease
hsa05171,C2,hsa05171,Coronavirus disease - COVID-19,9/25,238/8843,8.942962186934746e-09,2.4742195383852796e-07,2.039622954914942e-07,C1QB/C1R/C1S/C3/C5/C8A/C8B/C8G/MASP2,9,Human Diseases,Infectious disease: viral
hsa05150,C2,hsa05150,Staphylococcus aureus infection,6/25,100/8843,2.675909590003906e-07,5.552512399258105e-06,4.577213772375102e-06,C1QB/C1R/C1S/C3/C5/MASP2,6,Human Diseases,Infectious disease: bacterial
hsa05133,C2,hsa05133,Pertussis,5/25,78/8843,2.1706551785739987e-06,3.603287596432838e-05,2.9703702443644196e-05,C1QB/C1R/C1S/C3/C5,5,Human Diseases,Infectious disease: bacterial
hsa04810,C2,hsa04810,Regulation of actin cytoskeleton,5/25,230/8843,0.00039552764102866554,0.0054714657008965405,0.004510402924011099,ACTB/C5/C8A/C8B/C8G,5,Cellular Processes,Cell motility
hsa04936,C2,hsa04936,Alcoholic liver disease,4/25,144/8843,0.0006537625474140425,0.007751755919337933,0.006390160237881619,C1QB/C3/C5/CAMKK2,4,Human Diseases,Endocrine and metabolic disease
hsa04145,C2,hsa04145,Phagosome,4/25,157/8843,0.0009043416618811086,0.00865298456499969,0.007133088100507037,ACTB/C1R/C3/THBS1,4,Cellular Processes,Transport and catabolism
hsa05020,C2,hsa05020,Prion disease,5/25,278/8843,0.0009382754347590026,0.00865298456499969,0.007133088100507037,C1QB/C5/C8A/C8B/C8G,5,Human Diseases,Neurodegenerative disease
hsa05146,C2,hsa05146,Amoebiasis,3/25,103/8843,0.0029298628856893796,0.02431786195122185,0.02004643027050628,C8A/C8B/C8G,3,Human Diseases,Infectious disease: parasitic
R-HSA-166658,C2,R-HSA-166658,Complement cascade,12/35,58/11009,1.0350561167866953e-19,1.9045032548875193e-17,1.601613149133097e-17,C1QB/C1R/C1S/C3/C5/C8A/C8B/C8G/CPN2/FCN2/MASP2/PROS1,12,,
R-HSA-977606,C2,R-HSA-977606,Regulation of Complement cascade,10/35,47/11009,1.2268019761462304e-16,1.128657818054532e-14,9.491573183868205e-15,C1QB/C1R/C1S/C3/C5/C8A/C8B/C8G/CPN2/PROS1,10,,
R-HSA-166663,C2,R-HSA-166663,Initial triggering of complement,6/35,23/11009,6.385421163932783e-11,3.916391647212107e-09,3.2935330213969092e-09,C1QB/C1R/C1S/C3/FCN2/MASP2,6,,
R-HSA-166786,C2,R-HSA-166786,Creation of C4 and C2 activators,5/35,14/11009,4.729347327091981e-10,2.1754997704623112e-08,1.8295106765329506e-08,C1QB/C1R/C1S/FCN2/MASP2,5,,
R-HSA-8963899,C2,R-HSA-8963899,Plasma lipoprotein remodeling,3/35,34/11009,0.00016465306048729173,0.006059232625932335,0.005095578924554081,APOB/APOF/LCAT,3,,
R-HSA-8957275,C2,R-HSA-8957275,Post-translational protein phosphorylation,4/35,108/11009,0.00036287610729537206,0.011128200623724743,0.009358383819722753,APOB/C3/SERPINA10/SERPIND1,4,,
R-HSA-381426,C2,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),4/35,125/11009,0.000631593587947384,0.01635440111001513,0.013753415121122563,APOB/C3/SERPINA10/SERPIND1,4,,
R-HSA-114608,C2,R-HSA-114608,Platelet degranulation,4/35,129/11009,0.0007110609178267447,0.01635440111001513,0.013753415121122563,ITIH4/PROS1/SERPINF2/THBS1,4,,
R-HSA-76005,C2,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,4/35,134/11009,0.0008200680221537788,0.016765835119588363,0.014099415117731636,ITIH4/PROS1/SERPINF2/THBS1,4,,
R-HSA-174824,C2,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",3/35,75/11009,0.0016995068284140495,0.03127092564281851,0.026297631976512137,APOB/APOF/LCAT,3,,
R-HSA-140875,C2,R-HSA-140875,Common Pathway of Fibrin Clot Formation,2/35,22/11009,0.0021794897726622143,0.036456919833622495,0.030658851347497178,PROS1/SERPIND1,2,,
R-HSA-140837,C2,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,2/35,23/11009,0.0023823066908670574,0.03652870259329488,0.03071921785591732,PROS1/SERPIND1,2,,
GO:0006958,C2,GO:0006958,"complement activation, classical pathway",10/41,42/18870,9.992492937336315e-19,7.979694703661463e-16,5.99143019955742e-16,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,10,,
GO:0006956,C2,GO:0006956,complement activation,11/41,67/18870,1.386567281261766e-18,7.979694703661463e-16,5.99143019955742e-16,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/FCN2/MASP2,11,,
GO:0002455,C2,GO:0002455,humoral immune response mediated by circulating immunoglobulin,10/41,55/18870,1.9479686924273416e-17,7.473706549946235e-15,5.6115168297643774e-15,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,10,,
GO:0006959,C2,GO:0006959,humoral immune response,11/41,258/18870,5.5470145596984835e-12,1.5961534395532386e-09,1.1984470930295934e-09,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/FCN2/MASP2,11,,
GO:0016064,C2,GO:0016064,immunoglobulin mediated immune response,10/41,205/18870,1.536653355078515e-11,3.4044842545679167e-09,2.556204282774941e-09,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,10,,
GO:0019724,C2,GO:0019724,B cell mediated immunity,10/41,208/18870,1.774709428966768e-11,3.4044842545679167e-09,2.556204282774941e-09,C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,10,,
GO:0002443,C2,GO:0002443,leukocyte mediated immunity,12/41,466/18870,1.8438975283551297e-10,3.031894364481077e-08,2.2764509335030996e-08,B2M/C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2/PTGDS,12,,
GO:0002449,C2,GO:0002449,lymphocyte mediated immunity,11/41,368/18870,2.502487383894532e-10,3.600453723578258e-08,2.7033449239176457e-08,B2M/C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,11,,
GO:0006957,C2,GO:0006957,"complement activation, alternative pathway",5/41,18/18870,3.156156323780496e-10,4.036373254079279e-08,3.030648353010278e-08,C3/C5/C8A/C8B/C8G,5,,
GO:0002460,C2,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/41,380/18870,3.5159495042895927e-10,4.046857879437321e-08,3.0385205716018476e-08,B2M/C1QB/C1R/C1RL/C1S/C3/C5/C8A/C8B/C8G/MASP2,11,,
GO:0031638,C2,GO:0031638,zymogen activation,4/41,59/18870,8.005537162620296e-06,0.0006836035656174191,0.0005132731513758298,C1R/C1RL/SERPINF2/THBS1,4,,
GO:0001906,C2,GO:0001906,cell killing,6/41,223/18870,8.105101858678775e-06,0.0006836035656174191,0.0005132731513758298,B2M/C3/C5/C8A/C8B/C8G,6,,
GO:0010951,C2,GO:0010951,negative regulation of endopeptidase activity,5/41,128/18870,8.180659513068492e-06,0.0006836035656174191,0.0005132731513758298,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0007596,C2,GO:0007596,blood coagulation,6/41,224/18870,8.314900016197974e-06,0.0006836035656174191,0.0005132731513758298,ACTB/PROS1/SERPINA10/SERPIND1/SERPINF2/THBS1,6,,
GO:0050817,C2,GO:0050817,coagulation,6/41,229/18870,9.431099180949915e-06,0.0007129201696849276,0.0005352850695608629,ACTB/PROS1/SERPINA10/SERPIND1/SERPINF2/THBS1,6,,
GO:0007599,C2,GO:0007599,hemostasis,6/41,231/18870,9.910271689799168e-06,0.0007129201696849276,0.0005352850695608629,ACTB/PROS1/SERPINA10/SERPIND1/SERPINF2/THBS1,6,,
GO:0010466,C2,GO:0010466,negative regulation of peptidase activity,5/41,137/18870,1.1386822407279522e-05,0.0007709548582811017,0.0005788595168034977,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0042730,C2,GO:0042730,fibrinolysis,3/41,27/18870,2.6856018457230795e-05,0.001717293180237369,0.00128940299142611,PROS1/SERPINF2/THBS1,3,,
GO:0031640,C2,GO:0031640,killing of cells of another organism,4/41,92/18870,4.6670425753583646e-05,0.002685883002118739,0.0020166536601943248,C5/C8A/C8B/C8G,4,,
GO:0141061,C2,GO:0141061,disruption of cell in another organism,4/41,92/18870,4.6670425753583646e-05,0.002685883002118739,0.0020166536601943248,C5/C8A/C8B/C8G,4,,
GO:0141060,C2,GO:0141060,disruption of anatomical structure in another organism,4/41,99/18870,6.219002135142849e-05,0.003408605455975914,0.002559298623033724,C5/C8A/C8B/C8G,4,,
GO:0051346,C2,GO:0051346,negative regulation of hydrolase activity,5/41,218/18870,0.00010498040638563578,0.005492383988630309,0.004123871466153444,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0050878,C2,GO:0050878,regulation of body fluid levels,6/41,365/18870,0.00012756693868551294,0.006383893322914147,0.004793247444430486,ACTB/PROS1/SERPINA10/SERPIND1/SERPINF2/THBS1,6,,
GO:0045861,C2,GO:0045861,negative regulation of proteolysis,5/41,235/18870,0.00014923889327290876,0.006726713359466819,0.005050648560173999,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0030195,C2,GO:0030195,negative regulation of blood coagulation,3/41,48/18870,0.0001538516465763047,0.006726713359466819,0.005050648560173999,PROS1/SERPINF2/THBS1,3,,
GO:0043277,C2,GO:0043277,apoptotic cell clearance,3/41,48/18870,0.0001538516465763047,0.006726713359466819,0.005050648560173999,C3/FCN2/THBS1,3,,
GO:0090130,C2,GO:0090130,tissue migration,6/41,380/18870,0.00015884949484401488,0.006726713359466819,0.005050648560173999,ACTA1/ACTA2/CDH5/GPLD1/NRP2/THBS1,6,,
GO:1900047,C2,GO:1900047,negative regulation of hemostasis,3/41,49/18870,0.00016363855261952297,0.006726713359466819,0.005050648560173999,PROS1/SERPINF2/THBS1,3,,
GO:0050819,C2,GO:0050819,negative regulation of coagulation,3/41,52/18870,0.0001954024100241084,0.007755454273715475,0.0058230627451830485,PROS1/SERPINF2/THBS1,3,,
GO:0001867,C2,GO:0001867,"complement activation, lectin pathway",2/41,11/18870,0.00025020662682112565,0.009599594249037188,0.007207706688426111,FCN2/MASP2,2,,
GO:0042060,C2,GO:0042060,wound healing,6/41,423/18870,0.0002832970637537871,0.010518545818729321,0.007897687244205745,ACTB/PROS1/SERPINA10/SERPIND1/SERPINF2/THBS1,6,,
GO:0051918,C2,GO:0051918,negative regulation of fibrinolysis,2/41,13/18870,0.00035386246653286836,0.012727990593104109,0.009556614638930426,SERPINF2/THBS1,2,,
GO:0052548,C2,GO:0052548,regulation of endopeptidase activity,5/41,288/18870,0.00038224398745427665,0.013332206956359768,0.01001028113875474,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0098883,C2,GO:0098883,synapse pruning,2/41,14/18870,0.0004122714868836781,0.01395660239420922,0.010479098784256955,C1QB/C3,2,,
GO:0030193,C2,GO:0030193,regulation of blood coagulation,3/41,68/18870,0.0004325588027954909,0.014225005200503143,0.010680624875040541,PROS1/SERPINF2/THBS1,3,,
GO:1900046,C2,GO:1900046,regulation of hemostasis,3/41,70/18870,0.00047104854221440115,0.014777701695125272,0.011095608479306641,PROS1/SERPINF2/THBS1,3,,
GO:0010763,C2,GO:0010763,positive regulation of fibroblast migration,2/41,15/18870,0.0004750434080969896,0.014777701695125272,0.011095608479306641,ACTA2/THBS1,2,,
GO:0050818,C2,GO:0050818,regulation of coagulation,3/41,73/18870,0.0005327970439175573,0.016138142040766013,0.01211707404588129,PROS1/SERPINF2/THBS1,3,,
GO:0052547,C2,GO:0052547,regulation of peptidase activity,5/41,312/18870,0.0005504918935059959,0.016246568446805162,0.01219848433383057,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0061045,C2,GO:0061045,negative regulation of wound healing,3/41,75/18870,0.0005767086546230779,0.016594791536779063,0.012459942248567024,PROS1/SERPINF2/THBS1,3,,
GO:0098974,C2,GO:0098974,postsynaptic actin cytoskeleton organization,2/41,17/18870,0.0006136027891751347,0.01722577586196537,0.012933707058094625,ACTB/ACTBL2,2,,
GO:0010755,C2,GO:0010755,regulation of plasminogen activation,2/41,18/18870,0.0006893538059215697,0.01845223792129597,0.013854577103099355,SERPINF2/THBS1,2,,
GO:0051917,C2,GO:0051917,regulation of fibrinolysis,2/41,18/18870,0.0006893538059215697,0.01845223792129597,0.013854577103099355,SERPINF2/THBS1,2,,
GO:0099188,C2,GO:0099188,postsynaptic cytoskeleton organization,2/41,20/18870,0.0008537077990532395,0.022332219925233605,0.016767801507720326,ACTB/ACTBL2,2,,
GO:0097006,C2,GO:0097006,regulation of plasma lipoprotein particle levels,3/41,91/18870,0.001012886153435087,0.02534838624760061,0.019032443284356944,APOB/GPLD1/LCAT,3,,
GO:0010866,C2,GO:0010866,regulation of triglyceride biosynthetic process,2/41,22/18870,0.0010350774575475488,0.02534838624760061,0.019032443284356944,C3/GPLD1,2,,
GO:0150105,C2,GO:0150105,protein localization to cell-cell junction,2/41,22/18870,0.0010350774575475488,0.02534838624760061,0.019032443284356944,ACTB/CDH5,2,,
GO:0071636,C2,GO:0071636,positive regulation of transforming growth factor beta production,2/41,23/18870,0.0011320982617696017,0.02714677290201691,0.020382734055106204,SERPINF2/THBS1,2,,
GO:1903035,C2,GO:1903035,negative regulation of response to wounding,3/41,97/18870,0.0012182482915919233,0.02861640374739395,0.021486183617550354,PROS1/SERPINF2/THBS1,3,,
GO:0010884,C2,GO:0010884,positive regulation of lipid storage,2/41,27/18870,0.0015620051151942096,0.032771293374983614,0.024605818154338602,APOB/C3,2,,
GO:0031639,C2,GO:0031639,plasminogen activation,2/41,27/18870,0.0015620051151942096,0.032771293374983614,0.024605818154338602,SERPINF2/THBS1,2,,
GO:0034377,C2,GO:0034377,plasma lipoprotein particle assembly,2/41,27/18870,0.0015620051151942096,0.032771293374983614,0.024605818154338602,APOB/LCAT,2,,
GO:0150146,C2,GO:0150146,cell junction disassembly,2/41,27/18870,0.0015620051151942096,0.032771293374983614,0.024605818154338602,C1QB/C3,2,,
GO:0006641,C2,GO:0006641,triglyceride metabolic process,3/41,106/18870,0.0015726219110044168,0.032771293374983614,0.024605818154338602,APOB/C3/GPLD1,3,,
GO:0002526,C2,GO:0002526,acute inflammatory response,3/41,107/18870,0.0016155573061113052,0.032771293374983614,0.024605818154338602,C3/ITIH4/SERPINF2,3,,
GO:0010758,C2,GO:0010758,regulation of macrophage chemotaxis,2/41,28/18870,0.0016798490956768317,0.032771293374983614,0.024605818154338602,C5/THBS1,2,,
GO:0019433,C2,GO:0019433,triglyceride catabolic process,2/41,28/18870,0.0016798490956768317,0.032771293374983614,0.024605818154338602,APOB/GPLD1,2,,
GO:0030194,C2,GO:0030194,positive regulation of blood coagulation,2/41,28/18870,0.0016798490956768317,0.032771293374983614,0.024605818154338602,SERPINF2/THBS1,2,,
GO:1900048,C2,GO:1900048,positive regulation of hemostasis,2/41,28/18870,0.0016798490956768317,0.032771293374983614,0.024605818154338602,SERPINF2/THBS1,2,,
GO:0030203,C2,GO:0030203,glycosaminoglycan metabolic process,3/41,112/18870,0.0018412627928905837,0.0336206129422757,0.0252435165993949,ITIH1/ITIH4/PGLYRP2,3,,
GO:0016485,C2,GO:0016485,protein processing,4/41,245/18870,0.0019259223431405026,0.0336206129422757,0.0252435165993949,C1R/C1RL/SERPINF2/THBS1,4,,
GO:0010575,C2,GO:0010575,positive regulation of vascular endothelial growth factor production,2/41,30/18870,0.00192785443457011,0.0336206129422757,0.0252435165993949,C3/C5,2,,
GO:0010955,C2,GO:0010955,negative regulation of protein processing,2/41,30/18870,0.00192785443457011,0.0336206129422757,0.0252435165993949,SERPINF2/THBS1,2,,
GO:0050820,C2,GO:0050820,positive regulation of coagulation,2/41,30/18870,0.00192785443457011,0.0336206129422757,0.0252435165993949,SERPINF2/THBS1,2,,
GO:0065005,C2,GO:0065005,protein-lipid complex assembly,2/41,30/18870,0.00192785443457011,0.0336206129422757,0.0252435165993949,APOB/LCAT,2,,
GO:1903318,C2,GO:1903318,negative regulation of protein maturation,2/41,30/18870,0.00192785443457011,0.0336206129422757,0.0252435165993949,SERPINF2/THBS1,2,,
GO:0006022,C2,GO:0006022,aminoglycan metabolic process,3/41,121/18870,0.002295239044291573,0.0388736670853919,0.029187690957160138,ITIH1/ITIH4/PGLYRP2,3,,
GO:0034368,C2,GO:0034368,protein-lipid complex remodeling,2/41,33/18870,0.0023303935959096797,0.0388736670853919,0.029187690957160138,APOB/LCAT,2,,
GO:0034369,C2,GO:0034369,plasma lipoprotein particle remodeling,2/41,33/18870,0.0023303935959096797,0.0388736670853919,0.029187690957160138,APOB/LCAT,2,,
GO:0030212,C2,GO:0030212,hyaluronan metabolic process,2/41,34/18870,0.002472645386406977,0.040657354853634725,0.030526945296844035,ITIH1/ITIH4,2,,
GO:0034367,C2,GO:0034367,protein-containing complex remodeling,2/41,35/18870,0.0026189043791855315,0.04186609639503537,0.031434510165370196,APOB/LCAT,2,,
GO:0070633,C2,GO:0070633,transepithelial transport,2/41,35/18870,0.0026189043791855315,0.04186609639503537,0.031434510165370196,ACTB/GPLD1,2,,
GO:0010595,C2,GO:0010595,positive regulation of endothelial cell migration,3/41,130/18870,0.002813151173038951,0.04435530137216209,0.033303491176135236,GPLD1/NRP2/THBS1,3,,
GO:0002504,C2,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2/41,37/18870,0.0029233751434011904,0.04489705164528968,0.033710255979498685,B2M/THBS1,2,,
GO:0061041,C2,GO:0061041,regulation of wound healing,3/41,133/18870,0.003000494991380288,0.04489705164528968,0.033710255979498685,PROS1/SERPINF2/THBS1,3,,
GO:0006639,C2,GO:0006639,acylglycerol metabolic process,3/41,134/18870,0.0030646096241978477,0.04489705164528968,0.033710255979498685,APOB/C3/GPLD1,3,,
GO:0035633,C2,GO:0035633,maintenance of blood-brain barrier,2/41,38/18870,0.0030815526324742704,0.04489705164528968,0.033710255979498685,ACTB/CDH5,2,,
GO:0046461,C2,GO:0046461,neutral lipid catabolic process,2/41,38/18870,0.0030815526324742704,0.04489705164528968,0.033710255979498685,APOB/GPLD1,2,,
GO:0046464,C2,GO:0046464,acylglycerol catabolic process,2/41,38/18870,0.0030815526324742704,0.04489705164528968,0.033710255979498685,APOB/GPLD1,2,,
GO:0006638,C2,GO:0006638,neutral lipid metabolic process,3/41,135/18870,0.003129563684519503,0.04502659751102434,0.03380752348671726,APOB/C3/GPLD1,3,,
GO:0010762,C2,GO:0010762,regulation of fibroblast migration,2/41,39/18870,0.0032436687588229185,0.046085692001583765,0.034602728184462264,ACTA2/THBS1,2,,
GO:0043542,C2,GO:0043542,endothelial cell migration,4/41,284/18870,0.0032832552077583566,0.046085692001583765,0.034602728184462264,CDH5/GPLD1/NRP2/THBS1,4,,
GO:0008203,C2,GO:0008203,cholesterol metabolic process,3/41,140/18870,0.0034670501911382157,0.04807921409638658,0.0360995333788773,APOB/APOF/LCAT,3,,
GO:0048246,C2,GO:0048246,macrophage chemotaxis,2/41,41/18870,0.003579648935229724,0.04850025870715976,0.03641566820483622,C5/THBS1,2,,
GO:0030100,C2,GO:0030100,regulation of endocytosis,4/41,291/18870,0.003581687219903197,0.04850025870715976,0.03641566820483622,ACTB/B2M/C3/FCN2,4,,
GO:0043086,C2,GO:0043086,negative regulation of catalytic activity,5/41,480/18870,0.0036743822412951353,0.048796381287522644,0.03663800725872796,FETUB/SERPINA10/SERPIND1/SERPINF2/THBS1,5,,
GO:0032102,C2,GO:0032102,negative regulation of response to external stimulus,5/41,481/18870,0.0037070897336755194,0.048796381287522644,0.03663800725872796,C5/CDH5/PROS1/SERPINF2/THBS1,5,,
GO:0071634,C2,GO:0071634,regulation of transforming growth factor beta production,2/41,42/18870,0.003753479121574232,0.048796381287522644,0.03663800725872796,SERPINF2/THBS1,2,,
GO:0050808,C2,GO:0050808,synapse organization,5/41,483/18870,0.0037731346086789883,0.048796381287522644,0.03663800725872796,ACTB/ACTBL2/C1QB/C3/NRP2,5,,
HALLMARK_COAGULATION,C3,HALLMARK_COAGULATION,HALLMARK_COAGULATION,3/10,138/4383,0.003115351771526567,0.04673027657289851,0.042631129505100396,ANG/CFI/F9,3,,
hsa04610,C3,hsa04610,Complement and coagulation cascades,4/10,88/8843,1.837213406378291e-06,5.5116402191348726e-05,5.0281630069300595e-05,C4BPB/CFI/F9/KNG1,4,Organismal Systems,Immune system
R-HSA-140837,C3,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,2/12,23/11009,0.00027209029240382685,0.036188008889708974,0.02234004506052473,F9/KNG1,2,,
GO:0042060,C3,GO:0042060,wound healing,5/15,423/18870,1.3790095713155306e-05,0.007294960632259157,0.004587021310902186,APCS/C4BPB/CD44/F9/KNG1,5,,
GO:0006959,C3,GO:0006959,humoral immune response,4/15,258/18870,4.1389506231989155e-05,0.01094752439836113,0.006883728404899249,ANG/C4BPB/CFI/PPBP,4,,
HALLMARK_COAGULATION,C4,HALLMARK_COAGULATION,HALLMARK_COAGULATION,18/40,138/4383,1.9049547953570628e-17,5.524368906535482e-16,5.013038935150165e-16,APOC1/APOC2/APOC3/CLU/CPB2/CPN1/DPP4/F11/F13B/F2/FN1/HRG/KLKB1/LAMP2/MST1/PLG/PROC/PROZ,18,,
HALLMARK_COMPLEMENT,C4,HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,12/40,200/4383,1.0625697223970511e-07,1.540726097475724e-06,1.3981180557855934e-06,APOA4/APOC1/C1QC/CDH13/CLU/DPP4/F2/F7/FN1/KLKB1/LAMP2/PLG,12,,
HALLMARK_XENOBIOTIC_METABOLISM,C4,HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,7/40,200/4383,0.001913343480513447,0.01849565364496332,0.016783714741346028,F11/HGFAC/HRG/IGF1/PLG/SERPINA6/VTN,7,,
hsa04610,C4,hsa04610,Complement and coagulation cascades,16/47,88/8843,2.598702474935371e-21,2.3128452026924804e-19,2.0516072170542404e-19,C1QC/C4A/C4B/C6/CLU/CPB2/F11/F13A1/F13B/F2/F7/KLKB1/PLG/PROC/SERPINA5/VTN,16,Organismal Systems,Immune system
hsa04979,C4,hsa04979,Cholesterol metabolism,6/47,51/8843,2.437693879546306e-07,1.0847737763981063e-05,9.622475840314366e-06,APOA2/APOA4/APOC1/APOC2/APOC3/LPA,6,Organismal Systems,Digestive system
hsa05150,C4,hsa05150,Staphylococcus aureus infection,6/47,100/8843,1.3270988589731752e-05,0.00039370599482870867,0.0003492365418350461,C1QC/C4A/C4B/CAMP/KRT14/PLG,6,Human Diseases,Infectious disease: bacterial
hsa05171,C4,hsa05171,Coronavirus disease - COVID-19,7/47,238/8843,0.0002350280526780113,0.005229374172085752,0.004638711566013381,C1QC/C4A/C4B/C6/F13A1/F13B/F2,7,Human Diseases,Infectious disease: viral
R-HSA-977606,C4,R-HSA-977606,Regulation of Complement cascade,10/61,47/11009,5.564012211468322e-14,1.1239304667166011e-11,8.96098808794372e-12,C1QC/C4A/C4B/C6/CFP/CLU/CPB2/CPN1/F2/VTN,10,,
R-HSA-381426,C4,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),13/61,125/11009,1.1447873252655992e-13,1.1562351985182551e-11,9.218550566612457e-12,APOA2/APOL1/C4A/C4B/F2/FN1/IGF1/IGFALS/IGFBP3/ITIH2/PLG/PROC/QSOX1,13,,
R-HSA-166658,C4,R-HSA-166658,Complement cascade,10/61,58/11009,5.351800844119043e-13,3.603545901706822e-11,2.873072032106013e-11,C1QC/C4A/C4B/C6/CFP/CLU/CPB2/CPN1/F2/VTN,10,,
R-HSA-140877,C4,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),8/61,39/11009,2.971271203242448e-11,1.5004919576374362e-09,1.1963276160423542e-09,F11/F13A1/F13B/F2/F7/KLKB1/PROC/SERPINA5,8,,
R-HSA-114608,C4,R-HSA-114608,Platelet degranulation,11/61,129/11009,9.453904270190143e-11,3.819377325156818e-09,3.045152322819141e-09,A1BG/CLEC3B/CLU/F13A1/FN1/HRG/IGF1/LAMP2/PLG/QSOX1/SELENOP,11,,
R-HSA-76005,C4,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,11/61,134/11009,1.430378032099297e-10,4.815606041400966e-09,3.839435770371798e-09,A1BG/CLEC3B/CLU/F13A1/FN1/HRG/IGF1/LAMP2/PLG/QSOX1/SELENOP,11,,
R-HSA-8963898,C4,R-HSA-8963898,Plasma lipoprotein assembly,6/61,19/11009,5.769924636165808e-10,1.6650353950078473e-08,1.3275164952381483e-08,APOA2/APOA4/APOC1/APOC2/APOC3/APOC4,6,,
R-HSA-8957275,C4,R-HSA-8957275,Post-translational protein phosphorylation,9/61,108/11009,6.81110445128324e-09,1.719803873949018e-07,1.3711828697978104e-07,APOA2/APOL1/C4A/C4B/FN1/IGFBP3/ITIH2/PROC/QSOX1,9,,
R-HSA-76002,C4,R-HSA-76002,"Platelet activation, signaling and aggregation",12/61,263/11009,1.6556204637605535e-08,3.715948151995909e-07,2.9626892509399383e-07,A1BG/CLEC3B/CLU/F13A1/F2/FN1/HRG/IGF1/LAMP2/PLG/QSOX1/SELENOP,12,,
R-HSA-140875,C4,R-HSA-140875,Common Pathway of Fibrin Clot Formation,5/61,22/11009,1.0825354631177743e-07,2.186721635497904e-06,1.743451851126521e-06,F13A1/F13B/F2/PROC/SERPINA5,5,,
R-HSA-140837,C4,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,5/61,23/11009,1.3773780877741195e-07,2.206175457308492e-06,1.758962193685249e-06,F11/F2/KLKB1/PROC/SERPINA5,5,,
R-HSA-174824,C4,R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",7/61,75/11009,1.6647687820524688e-07,2.206175457308492e-06,1.758962193685249e-06,APOA2/APOA4/APOC1/APOC2/APOC3/APOC4/LPA,7,,
R-HSA-159740,C4,R-HSA-159740,Gamma-carboxylation of protein precursors,4/61,10/11009,1.7474657087592016e-07,2.206175457308492e-06,1.758962193685249e-06,F2/F7/PROC/PROZ,4,,
R-HSA-159782,C4,R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,4/61,10/11009,1.7474657087592016e-07,2.206175457308492e-06,1.758962193685249e-06,F2/F7/PROC/PROZ,4,,
R-HSA-8963888,C4,R-HSA-8963888,Chylomicron assembly,4/61,10/11009,1.7474657087592016e-07,2.206175457308492e-06,1.758962193685249e-06,APOA2/APOA4/APOC2/APOC3,4,,
R-HSA-8963901,C4,R-HSA-8963901,Chylomicron remodeling,4/61,10/11009,1.7474657087592016e-07,2.206175457308492e-06,1.758962193685249e-06,APOA2/APOA4/APOC2/APOC3,4,,
R-HSA-159854,C4,R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",4/61,11/11009,2.734645930381041e-07,3.249402811393943e-06,2.5907171972030914e-06,F2/F7/PROC/PROZ,4,,
R-HSA-8963899,C4,R-HSA-8963899,Plasma lipoprotein remodeling,5/61,34/11009,1.0870362369145403e-06,1.2198962214263173e-05,9.726113698709046e-06,APOA2/APOA4/APOC2/APOC3/LPA,5,,
R-HSA-975634,C4,R-HSA-975634,Retinoid metabolism and transport,5/61,44/11009,4.066343346523088e-06,4.323165031566652e-05,3.4468173519004574e-05,APOA2/APOA4/APOC2/APOC3/TTR,5,,
R-HSA-6806667,C4,R-HSA-6806667,Metabolism of fat-soluble vitamins,5/61,48/11009,6.303518723778824e-06,6.366553911016612e-05,5.075991393358737e-05,APOA2/APOA4/APOC2/APOC3/TTR,5,,
R-HSA-166663,C4,R-HSA-166663,Initial triggering of complement,4/61,23/11009,6.981734799761542e-06,6.715763950246816e-05,5.3544131547043414e-05,C1QC/C4A/C4B/CFP,4,,
R-HSA-9651496,C4,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),3/61,16/11009,8.61118847493369e-05,0.0007562869877985241,0.0006029802456132059,F11/F2/KLKB1,3,,
R-HSA-9671793,C4,R-HSA-9671793,Diseases of hemostasis,3/61,16/11009,8.61118847493369e-05,0.0007562869877985241,0.0006029802456132059,F11/F2/KLKB1,3,,
R-HSA-2187338,C4,R-HSA-2187338,Visual phototransduction,5/61,104/11009,0.0002670621944030225,0.0022477734695587723,0.0017921278834939667,APOA2/APOA4/APOC2/APOC3/TTR,5,,
R-HSA-163841,C4,R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",4/61,61/11009,0.0003516113899409904,0.0028410200307232023,0.002265117585725118,F2/F7/PROC/PROZ,4,,
R-HSA-196854,C4,R-HSA-196854,Metabolism of vitamins and cofactors,6/61,194/11009,0.0006878196648989125,0.005343829704214628,0.00426058334937383,APOA2/APOA4/APOC2/APOC3/BTD/TTR,6,,
R-HSA-9029569,C4,R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,3/61,37/11009,0.001099869203860519,0.008228651080734254,0.006560623321273272,APOC1/APOC2/APOC4,3,,
R-HSA-6798695,C4,R-HSA-6798695,Neutrophil degranulation,9/61,480/11009,0.0012140028779910963,0.008758163619792909,0.00698279850874578,A1BG/CAMP/CFP/FUCA1/GDI2/LAMP2/PTPRJ/QSOX1/TTR,9,,
R-HSA-8964058,C4,R-HSA-8964058,HDL remodeling,2/61,10/11009,0.0013207363775703477,0.009199612009283112,0.00733476100792244,APOC2/APOC3,2,,
R-HSA-2980736,C4,R-HSA-2980736,Peptide hormone metabolism,4/61,89/11009,0.001465805266376833,0.009869755460270677,0.00786905985107563,BCHE/CPB2/DPP4/IGF1,4,,
R-HSA-9024446,C4,R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,3/61,47/11009,0.00220683218090366,0.014297217280869317,0.011399032016534683,APOC1/APOC2/APOC4,3,,
R-HSA-75205,C4,R-HSA-75205,Dissolution of Fibrin Clot,2/61,13/11009,0.0022649057078604857,0.014297217280869317,0.011399032016534683,HRG/PLG,2,,
R-HSA-3000171,C4,R-HSA-3000171,Non-integrin membrane-ECM interactions,3/61,59/11009,0.004221060943277588,0.025838009410365844,0.020600393120302107,FN1/TTR/VTN,3,,
R-HSA-422085,C4,R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",2/61,19/11009,0.0048603957278773174,0.028051426772320517,0.02236512921399187,BCHE/IGF1,2,,
R-HSA-8963889,C4,R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,2/61,19/11009,0.0048603957278773174,0.028051426772320517,0.02236512921399187,APOA4/APOC2,2,,
R-HSA-1474244,C4,R-HSA-1474244,Extracellular matrix organization,6/61,300/11009,0.00615016812836843,0.03450927672028952,0.02751391004796403,COL6A1/FN1/KLKB1/PLG/TTR/VTN,6,,
R-HSA-1474228,C4,R-HSA-1474228,Degradation of the extracellular matrix,4/61,140/11009,0.0074657739250611945,0.040759090077361115,0.03249682533525926,COL6A1/FN1/KLKB1/PLG,4,,
R-HSA-3000178,C4,R-HSA-3000178,ECM proteoglycans,3/61,76/11009,0.008541103613344406,0.04540270868146237,0.03619913719783086,COL6A1/FN1/VTN,3,,
R-HSA-6806834,C4,R-HSA-6806834,Signaling by MET,3/61,79/11009,0.009495942102650534,0.04897049613292183,0.03904369936600855,FN1/HGFAC/PTPRJ,3,,
R-HSA-3000170,C4,R-HSA-3000170,Syndecan interactions,2/61,27/11009,0.009697127947113233,0.04897049613292183,0.03904369936600855,FN1/VTN,2,,
GO:0051917,C4,GO:0051917,regulation of fibrinolysis,7/68,18/18870,1.771132372403466e-13,2.729314985873741e-10,2.0545135519880207e-10,CPB2/F11/F2/HRG/KLKB1/PLG/VTN,7,,
GO:0007596,C4,GO:0007596,blood coagulation,13/68,224/18870,1.155893576077503e-12,6.589355029032452e-10,4.960189379414435e-10,CPB2/F11/F13A1/F13B/F2/F7/HGFAC/HRG/KLKB1/PLG/PROC/PROZ/VTN,13,,
GO:0050817,C4,GO:0050817,coagulation,13/68,229/18870,1.5312646933993537e-12,6.589355029032452e-10,4.960189379414435e-10,CPB2/F11/F13A1/F13B/F2/F7/HGFAC/HRG/KLKB1/PLG/PROC/PROZ/VTN,13,,
GO:0007599,C4,GO:0007599,hemostasis,13/68,231/18870,1.710410130832564e-12,6.589355029032452e-10,4.960189379414435e-10,CPB2/F11/F13A1/F13B/F2/F7/HGFAC/HRG/KLKB1/PLG/PROC/PROZ/VTN,13,,
GO:0030193,C4,GO:0030193,regulation of blood coagulation,9/68,68/18870,2.464372781578357e-12,7.595196912824496e-10,5.717344853261788e-10,CPB2/F11/F2/F7/HRG/KLKB1/PLG/PROC/VTN,9,,
GO:1900046,C4,GO:1900046,regulation of hemostasis,9/68,70/18870,3.233857115220487e-12,8.30562302425795e-10,6.252123756092942e-10,CPB2/F11/F2/F7/HRG/KLKB1/PLG/PROC/VTN,9,,
GO:0050818,C4,GO:0050818,regulation of coagulation,9/68,73/18870,4.7867937406788314e-12,9.28026950943652e-10,6.985796645649814e-10,CPB2/F11/F2/F7/HRG/KLKB1/PLG/PROC/VTN,9,,
GO:0042730,C4,GO:0042730,fibrinolysis,7/68,27/18870,4.81779079010332e-12,9.28026950943652e-10,6.985796645649814e-10,CPB2/F11/F2/HRG/KLKB1/PLG/VTN,7,,
GO:0030195,C4,GO:0030195,negative regulation of blood coagulation,8/68,48/18870,6.255972202658334e-12,1.0711614626996104e-09,8.063253061204075e-10,CPB2/F11/F2/HRG/KLKB1/PLG/PROC/VTN,8,,
GO:1900047,C4,GO:1900047,negative regulation of hemostasis,8/68,49/18870,7.455499050841015e-12,1.1488924037346004e-09,8.648378898975579e-10,CPB2/F11/F2/HRG/KLKB1/PLG/PROC/VTN,8,,
GO:0050819,C4,GO:0050819,negative regulation of coagulation,8/68,52/18870,1.2335557823761722e-11,1.7280995096742558e-09,1.3008406432330542e-09,CPB2/F11/F2/HRG/KLKB1/PLG/PROC/VTN,8,,
GO:0042060,C4,GO:0042060,wound healing,15/68,423/18870,2.126210627900884e-11,2.7304088146627184e-09,2.0553369403041883e-09,CPB2/F11/F13A1/F13B/F2/F7/FN1/HGFAC/HRG/IGF1/KLKB1/PLG/PROC/PROZ/VTN,15,,
GO:1903035,C4,GO:1903035,negative regulation of response to wounding,9/68,97/18870,6.584969265610223e-11,7.805721260234886e-09,5.875818729313738e-09,CPB2/F11/F2/HRG/KLKB1/NEO1/PLG/PROC/VTN,9,,
GO:0061045,C4,GO:0061045,negative regulation of wound healing,8/68,75/18870,2.591018272448749e-10,2.851970827031087e-08,2.146843711457535e-08,CPB2/F11/F2/HRG/KLKB1/PLG/PROC/VTN,8,,
GO:0050878,C4,GO:0050878,regulation of body fluid levels,13/68,365/18870,5.152611598596996e-10,5.293449648958647e-08,3.98468630291501e-08,CPB2/F11/F13A1/F13B/F2/F7/HGFAC/HRG/KLKB1/PLG/PROC/PROZ/VTN,13,,
GO:1903034,C4,GO:1903034,regulation of response to wounding,10/68,173/18870,5.937803340335675e-10,5.295371326017634e-08,3.986132860597311e-08,CPB2/F11/F2/F7/HRG/KLKB1/NEO1/PLG/PROC/VTN,10,,
GO:0030194,C4,GO:0030194,positive regulation of blood coagulation,6/68,28/18870,6.185378576788929e-10,5.295371326017634e-08,3.986132860597311e-08,CPB2/F2/F7/HRG/PLG/VTN,6,,
GO:1900048,C4,GO:1900048,positive regulation of hemostasis,6/68,28/18870,6.185378576788929e-10,5.295371326017634e-08,3.986132860597311e-08,CPB2/F2/F7/HRG/PLG/VTN,6,,
GO:0051918,C4,GO:0051918,negative regulation of fibrinolysis,5/68,13/18870,6.583987424075194e-10,5.339960326578881e-08,4.0196975852248554e-08,CPB2/F2/HRG/PLG/VTN,5,,
GO:0050820,C4,GO:0050820,positive regulation of coagulation,6/68,30/18870,9.693860592049377e-10,7.469119586174045e-08,5.622439143388639e-08,CPB2/F2/F7/HRG/PLG/VTN,6,,
GO:0033700,C4,GO:0033700,phospholipid efflux,5/68,14/18870,1.021326397846361e-09,7.494590376577344e-08,5.6416124833418044e-08,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0016485,C4,GO:0016485,protein processing,11/68,245/18870,1.1280894622535713e-09,7.588345433899622e-08,5.7121873480360566e-08,BCHE/CD5L/CLEC3B/CPB2/CPN1/DPP4/F11/F7/HGFAC/KLKB1/NAGLU,11,,
GO:0061041,C4,GO:0061041,regulation of wound healing,9/68,133/18870,1.1325888707312869e-09,7.588345433899622e-08,5.7121873480360566e-08,CPB2/F11/F2/F7/HRG/KLKB1/PLG/PROC/VTN,9,,
GO:0006956,C4,GO:0006956,complement activation,7/68,67/18870,4.212461829254998e-09,2.70475153286748e-07,2.036023217473249e-07,C1QC/C4A/C4B/C6/CD5L/CFP/CLU,7,,
GO:0030100,C4,GO:0030100,regulation of endocytosis,11/68,291/18870,6.828698281150863e-09,4.2092096205013925e-07,3.1685160024540007e-07,APOA2/APOC1/APOC2/APOC3/C4A/C4B/CDH13/CFP/CLU/PTPRJ/VTN,11,,
GO:0043691,C4,GO:0043691,reverse cholesterol transport,5/68,20/18870,7.778312029234213e-09,4.610145706557662e-07,3.470323828427572e-07,APOA2/APOA4/APOC2/APOC3/CLU,5,,
GO:0006959,C4,GO:0006959,humoral immune response,10/68,258/18870,2.779071208239343e-08,1.586129159961788e-06,1.1939713339102364e-06,C1QC/C4A/C4B/C6/CAMP/CD5L/CFP/CLU/F2/HRG,10,,
GO:0031638,C4,GO:0031638,zymogen activation,6/68,59/18870,6.778425171036939e-08,3.7305547102028294e-06,2.8082047137153033e-06,CD5L/CLEC3B/CPB2/F11/HGFAC/KLKB1,6,,
GO:0034370,C4,GO:0034370,triglyceride-rich lipoprotein particle remodeling,4/68,12/18870,7.468909728506563e-08,3.836529963876205e-06,2.887978428355871e-06,APOA2/APOA4/APOC2/APOC3,4,,
GO:0034372,C4,GO:0034372,very-low-density lipoprotein particle remodeling,4/68,12/18870,7.468909728506563e-08,3.836529963876205e-06,2.887978428355871e-06,APOA2/APOA4/APOC2/APOC3,4,,
GO:0090303,C4,GO:0090303,positive regulation of wound healing,6/68,62/18870,9.170313837476023e-08,4.558533426951791e-06,3.4314722746684476e-06,CPB2/F2/F7/HRG/PLG/VTN,6,,
GO:0034368,C4,GO:0034368,protein-lipid complex remodeling,5/68,33/18870,1.1483728701957518e-07,5.362553312035313e-06,4.036704634627492e-06,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0034369,C4,GO:0034369,plasma lipoprotein particle remodeling,5/68,33/18870,1.1483728701957518e-07,5.362553312035313e-06,4.036704634627492e-06,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0034367,C4,GO:0034367,protein-containing complex remodeling,5/68,35/18870,1.5620411378881444e-07,7.079721745545972e-06,5.329316823383081e-06,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0033344,C4,GO:0033344,cholesterol efflux,6/68,73/18870,2.461843260348726e-07,1.0839144183421105e-05,8.159251948584348e-06,APOA2/APOA4/APOC1/APOC2/APOC3/PON1,6,,
GO:0034375,C4,GO:0034375,high-density lipoprotein particle remodeling,4/68,16/18870,2.716474486485597e-07,1.1313749145065689e-05,8.51651460627917e-06,APOA2/APOA4/APOC1/APOC3,4,,
GO:0051004,C4,GO:0051004,regulation of lipoprotein lipase activity,4/68,16/18870,2.716474486485597e-07,1.1313749145065689e-05,8.51651460627917e-06,APOA4/APOC1/APOC2/APOC3,4,,
GO:1903036,C4,GO:1903036,positive regulation of response to wounding,6/68,77/18870,3.390370574273452e-07,1.3748844881461552e-05,1.0349552279361065e-05,CPB2/F2/F7/HRG/PLG/VTN,6,,
GO:0030301,C4,GO:0030301,cholesterol transport,7/68,128/18870,3.85185329471371e-07,1.5219758787573914e-05,1.1456794415045907e-05,APOA2/APOA4/APOC1/APOC2/APOC3/CLU/PON1,7,,
GO:0006958,C4,GO:0006958,"complement activation, classical pathway",5/68,42/18870,4.014200284646934e-07,1.546470659660231e-05,1.1641180825476111e-05,C1QC/C4A/C4B/C6/CLU,5,,
GO:0032371,C4,GO:0032371,regulation of sterol transport,6/68,80/18870,4.26088556489924e-07,1.5633392036927926e-05,1.1768160131626473e-05,APOA2/APOA4/APOC1/APOC2/APOC3/PON1,6,,
GO:0032374,C4,GO:0032374,regulation of cholesterol transport,6/68,80/18870,4.26088556489924e-07,1.5633392036927926e-05,1.1768160131626473e-05,APOA2/APOA4/APOC1/APOC2/APOC3/PON1,6,,
GO:0006869,C4,GO:0006869,lipid transport,11/68,453/18870,6.044736948165231e-07,2.1662650318889817e-05,1.6306732232259695e-05,APOA2/APOA4/APOC1/APOC2/APOC3/APOC4/APOL1/CLU/LPA/PON1/SERPINA5,11,,
GO:0015918,C4,GO:0015918,sterol transport,7/68,141/18870,7.422062688041018e-07,2.5994087732434563e-05,1.9567256177562684e-05,APOA2/APOA4/APOC1/APOC2/APOC3/CLU/PON1,7,,
GO:0071827,C4,GO:0071827,plasma lipoprotein particle organization,5/68,50/18870,9.778050529300194e-07,3.348439081255911e-05,2.5205641364418284e-05,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0032102,C4,GO:0032102,negative regulation of response to external stimulus,11/68,481/18870,1.0885497491872527e-06,3.646641659777297e-05,2.7450384979504638e-05,CPB2/DPP4/F11/F2/HRG/IGF1/KLKB1/NEO1/PLG/PROC/VTN,11,,
GO:0051346,C4,GO:0051346,negative regulation of hydrolase activity,8/68,218/18870,1.1374117202209702e-06,3.729258427362798e-05,2.80722892650282e-05,APOA2/APOC1/APOC3/HRG/SERPINA5/SERPINA6/SERPINF1/VTN,8,,
GO:0071825,C4,GO:0071825,protein-lipid complex organization,5/68,53/18870,1.3133479962399045e-06,4.21639429626186e-05,3.1739243242464354e-05,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0045807,C4,GO:0045807,positive regulation of endocytosis,7/68,155/18870,1.4031481879545711e-06,4.4127578727306006e-05,3.321738567402659e-05,APOA2/C4A/C4B/CFP/CLU/PTPRJ/VTN,7,,
GO:0002455,C4,GO:0002455,humoral immune response mediated by circulating immunoglobulin,5/68,55/18870,1.5832656516072307e-06,4.879624738253485e-05,3.6731763117287756e-05,C1QC/C4A/C4B/C6/CLU,5,,
GO:0031639,C4,GO:0031639,plasminogen activation,4/68,27/18870,2.5424028349572166e-06,7.53431301667129e-05,5.671514016443022e-05,CLEC3B/CPB2/F11/KLKB1,4,,
GO:0034377,C4,GO:0034377,plasma lipoprotein particle assembly,4/68,27/18870,2.5424028349572166e-06,7.53431301667129e-05,5.671514016443022e-05,APOA2/APOA4/APOC1/APOC3,4,,
GO:0050994,C4,GO:0050994,regulation of lipid catabolic process,5/68,61/18870,2.6627832232961587e-06,7.742167824715812e-05,5.827978375516121e-05,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0051873,C4,GO:0051873,killing by host of symbiont cells,4/68,28/18870,2.9580999107985183e-06,8.441540671371327e-05,6.354436845419039e-05,APOL1/CAMP/F2/HRG,4,,
GO:0046503,C4,GO:0046503,glycerolipid catabolic process,5/68,65/18870,3.6561510082874364e-06,0.00010243870370492618,7.711154853842593e-05,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0065005,C4,GO:0065005,protein-lipid complex assembly,4/68,30/18870,3.937878899841481e-06,0.00010836198901170934,8.157034863957354e-05,APOA2/APOA4/APOC1/APOC3,4,,
GO:1905952,C4,GO:1905952,regulation of lipid localization,7/68,183/18870,4.233757143574407e-06,0.00011445999575873967,8.616067169379495e-05,APOA2/APOA4/APOC1/APOC2/APOC3/APOC4/PON1,7,,
GO:0032372,C4,GO:0032372,negative regulation of sterol transport,4/68,31/18870,4.5090206431331375e-06,0.00011776950527234177,8.865193128871931e-05,APOA2/APOC1/APOC2/APOC3,4,,
GO:0032375,C4,GO:0032375,negative regulation of cholesterol transport,4/68,31/18870,4.5090206431331375e-06,0.00011776950527234177,8.865193128871931e-05,APOA2/APOC1/APOC2/APOC3,4,,
GO:0051702,C4,GO:0051702,biological process involved in interaction with symbiont,6/68,121/18870,4.855089010749431e-06,0.00012469486942608121,9.386505420782234e-05,APOL1/CAMP/F2/FN1/HRG/PLG,6,,
GO:0031099,C4,GO:0031099,regeneration,7/68,191/18870,5.611708496571766e-06,0.00014176463595437855,0.00010671445665611884,APOA2/APOA4/CPB2/F7/IGF1/NEO1/VTN,7,,
GO:0050766,C4,GO:0050766,positive regulation of phagocytosis,5/68,72/18870,6.073833400957569e-06,0.00015096414953025186,0.00011363946363081905,APOA2/C4A/C4B/CFP/PTPRJ,5,,
GO:0043086,C4,GO:0043086,negative regulation of catalytic activity,10/68,480/18870,8.010712004406767e-06,0.00019594455871096552,0.00014749882420812463,AOC3/APOA2/APOC1/APOC3/HRG/PTPRJ/SERPINA5/SERPINA6/SERPINF1/VTN,10,,
GO:0060191,C4,GO:0060191,regulation of lipase activity,5/68,78/18870,9.012898927845619e-06,0.0002170137069970328,0.00016335879306720187,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0046461,C4,GO:0046461,neutral lipid catabolic process,4/68,38/18870,1.0378988917939065e-05,0.0002423336654930924,0.00018241859310317148,APOA2/APOA4/APOC2/APOC3,4,,
GO:0046464,C4,GO:0046464,acylglycerol catabolic process,4/68,38/18870,1.0378988917939065e-05,0.0002423336654930924,0.00018241859310317148,APOA2/APOA4/APOC2/APOC3,4,,
GO:0010896,C4,GO:0010896,regulation of triglyceride catabolic process,3/68,13/18870,1.2474337565190042e-05,0.00028690976399937094,0.00021597360560627536,APOA4/APOC2/APOC3,3,,
GO:0044242,C4,GO:0044242,cellular lipid catabolic process,7/68,223/18870,1.5403623078057832e-05,0.00034907328181304586,0.00026276768780216306,APOA2/APOA4/APOC1/APOC2/APOC3/FUCA1/NAGLU,7,,
GO:0055090,C4,GO:0055090,acylglycerol homeostasis,4/68,43/18870,1.7118855119457134e-05,0.0003768593677011921,0.00028368388483671823,APOA4/APOC2/APOC3/APOC4,4,,
GO:0070328,C4,GO:0070328,triglyceride homeostasis,4/68,43/18870,1.7118855119457134e-05,0.0003768593677011921,0.00028368388483671823,APOA4/APOC2/APOC3/APOC4,4,,
GO:0032368,C4,GO:0032368,regulation of lipid transport,6/68,153/18870,1.8624328855905154e-05,0.0004042266305204203,0.0003042848094767603,APOA2/APOA4/APOC1/APOC2/APOC3/PON1,6,,
GO:0097006,C4,GO:0097006,regulation of plasma lipoprotein particle levels,5/68,91/18870,1.9149623317329364e-05,0.0004098551323889521,0.00030852170900141755,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0044403,C4,GO:0044403,biological process involved in symbiotic interaction,8/68,322/18870,2.0011472142574158e-05,0.0004149193936415998,0.00031233387191710306,APOL1/CAMP/DPP4/F2/FN1/HRG/PLG/TFRC,8,,
GO:0031640,C4,GO:0031640,killing of cells of another organism,5/68,92/18870,2.0194000339467868e-05,0.0004149193936415998,0.00031233387191710306,APOL1/C6/CAMP/F2/HRG,5,,
GO:0141061,C4,GO:0141061,disruption of cell in another organism,5/68,92/18870,2.0194000339467868e-05,0.0004149193936415998,0.00031233387191710306,APOL1/C6/CAMP/F2/HRG,5,,
GO:0045861,C4,GO:0045861,negative regulation of proteolysis,7/68,235/18870,2.159381930166291e-05,0.00043784309926134924,0.00032958987355169705,CPB2/F2/HRG/SERPINA5/SERPINA6/SERPINF1/VTN,7,,
GO:0032369,C4,GO:0032369,negative regulation of lipid transport,4/68,48/18870,2.662800615556207e-05,0.0005329059413730019,0.00040114918364223375,APOA2/APOC1/APOC2/APOC3,4,,
GO:0141060,C4,GO:0141060,disruption of anatomical structure in another organism,5/68,99/18870,2.8804608975155175e-05,0.0005690756721886426,0.0004283762360407693,APOL1/C6/CAMP/F2/HRG,5,,
GO:0060192,C4,GO:0060192,negative regulation of lipase activity,3/68,17/18870,2.935436506245401e-05,0.0005725959058385016,0.000431026119904388,APOA2/APOC1/APOC3,3,,
GO:0050764,C4,GO:0050764,regulation of phagocytosis,5/68,100/18870,3.0236555363651273e-05,0.0005824316476923326,0.00043843005277294353,APOA2/C4A/C4B/CFP/PTPRJ,5,,
GO:0015914,C4,GO:0015914,phospholipid transport,5/68,103/18870,3.486616147003408e-05,0.0006602694056984383,0.0004970230438742301,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0034384,C4,GO:0034384,high-density lipoprotein particle clearance,3/68,18/18870,3.513438758421281e-05,0.0006602694056984383,0.0004970230438742301,APOA2/APOC2/APOC3,3,,
GO:0006898,C4,GO:0006898,receptor-mediated endocytosis,7/68,258/18870,3.921215841978865e-05,0.0007280233268059556,0.0005480253465898173,APOC1/APOC2/APOC3/CLU/DPP4/TFRC/VTN,7,,
GO:0006641,C4,GO:0006641,triglyceride metabolic process,5/68,106/18870,4.0027513070348985e-05,0.0007343142576358069,0.0005527608947810098,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0072376,C4,GO:0072376,protein activation cascade,3/68,19/18870,4.1614492798822106e-05,0.0007544462753292337,0.0005679154311368664,F13A1/F13B/KLKB1,3,,
GO:0034381,C4,GO:0034381,plasma lipoprotein particle clearance,4/68,55/18870,4.579636626102348e-05,0.0008111747173360595,0.0006106182168136465,APOA2/APOC1/APOC2/APOC3,4,,
GO:0042304,C4,GO:0042304,regulation of fatty acid biosynthetic process,4/68,55/18870,4.579636626102348e-05,0.0008111747173360595,0.0006106182168136465,APOA4/APOC1/APOC2/APOC3,4,,
GO:0010985,C4,GO:0010985,negative regulation of lipoprotein particle clearance,3/68,21/18870,5.68237793978829e-05,0.0009950618642288358,0.0007490407284266383,APOC1/APOC2/APOC3,3,,
GO:0048259,C4,GO:0048259,regulation of receptor-mediated endocytosis,5/68,115/18870,5.912417699485464e-05,0.0010237118735850674,0.0007706072507194536,APOC1/APOC2/APOC3/CLU/VTN,5,,
GO:0010811,C4,GO:0010811,positive regulation of cell-substrate adhesion,5/68,123/18870,8.14105451132795e-05,0.0013939294446618192,0.001049291470348936,CDH13/FN1/HRG/PTPRJ/VTN,5,,
GO:0031100,C4,GO:0031100,animal organ regeneration,4/68,64/18870,8.326400616777276e-05,0.0014099981703795366,0.001061387331369411,APOA2/CPB2/F7/VTN,4,,
GO:1905953,C4,GO:1905953,negative regulation of lipid localization,4/68,66/18870,9.393834454298111e-05,0.0015734672710949337,0.0011844399964115009,APOA2/APOC1/APOC2/APOC3,4,,
GO:0016064,C4,GO:0016064,immunoglobulin mediated immune response,6/68,205/18870,9.548928580431978e-05,0.0015822471981124385,0.001191049156268935,C1QC/C4A/C4B/C6/CLU/TFRC,6,,
GO:0010951,C4,GO:0010951,negative regulation of endopeptidase activity,5/68,128/18870,9.830920703548377e-05,0.0016116434898051117,0.0012131774485229913,HRG/SERPINA5/SERPINA6/SERPINF1/VTN,5,,
GO:0019724,C4,GO:0019724,B cell mediated immunity,6/68,208/18870,0.00010342246247453169,0.0016776212070868772,0.0012628426996890189,C1QC/C4A/C4B/C6/CLU/TFRC,6,,
GO:0015850,C4,GO:0015850,organic hydroxy compound transport,7/68,308/18870,0.000119199071414694,0.0019133934276046192,0.0014403221129275527,APOA2/APOA4/APOC1/APOC2/APOC3/CLU/PON1,7,,
GO:0006639,C4,GO:0006639,acylglycerol metabolic process,5/68,134/18870,0.00012201024332145032,0.0019153507319476612,0.0014417954893311403,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0050995,C4,GO:0050995,negative regulation of lipid catabolic process,3/68,27/18870,0.00012304978745153697,0.0019153507319476612,0.0014417954893311403,APOA2/APOC1/APOC3,3,,
GO:0050996,C4,GO:0050996,positive regulation of lipid catabolic process,3/68,27/18870,0.00012304978745153697,0.0019153507319476612,0.0014417954893311403,APOA2/APOA4/APOC2,3,,
GO:0006638,C4,GO:0006638,neutral lipid metabolic process,5/68,135/18870,0.0001263520786057135,0.0019278074567465793,0.0014511723879468087,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0042157,C4,GO:0042157,lipoprotein metabolic process,5/68,135/18870,0.0001263520786057135,0.0019278074567465793,0.0014511723879468087,APOA2/APOA4/APOC1/APOC3/APOL1,5,,
GO:0010466,C4,GO:0010466,negative regulation of peptidase activity,5/68,137/18870,0.00013539048886887503,0.0020454582681072196,0.0015397349714499514,HRG/SERPINA5/SERPINA6/SERPINF1/VTN,5,,
GO:0019433,C4,GO:0019433,triglyceride catabolic process,3/68,28/18870,0.0001374607899564252,0.0020565735662412743,0.0015481021004801283,APOA4/APOC2/APOC3,3,,
GO:0010810,C4,GO:0010810,regulation of cell-substrate adhesion,6/68,220/18870,0.00014055895602044276,0.002082705300264445,0.0015677729709972462,CDH13/FN1/HRG/PLG/PTPRJ/VTN,6,,
GO:0008203,C4,GO:0008203,cholesterol metabolic process,5/68,140/18870,0.00014986752405007531,0.0021994843291539626,0.001655679313315118,APOA2/APOA4/APOC1/APOL1/PON1,5,,
GO:0001906,C4,GO:0001906,cell killing,6/68,223/18870,0.0001513194093026685,0.0021998416012774732,0.0016559482527461838,APOL1/C6/CAMP/CD5L/F2/HRG,6,,
GO:0046470,C4,GO:0046470,phosphatidylcholine metabolic process,4/68,76/18870,0.00016276049299287013,0.002344055324317877,0.001764506279175041,APOA2/APOA4/APOC1/PON1,4,,
GO:0016042,C4,GO:0016042,lipid catabolic process,7/68,334/18870,0.0001963415388491716,0.002801502883023828,0.0021088535654170287,APOA2/APOA4/APOC1/APOC2/APOC3/FUCA1/NAGLU,7,,
GO:1902652,C4,GO:1902652,secondary alcohol metabolic process,5/68,150/18870,0.00020682251381580095,0.0029051216718365917,0.002186853432401328,APOA2/APOA4/APOC1/APOL1/PON1,5,,
GO:0062012,C4,GO:0062012,regulation of small molecule metabolic process,7/68,337/18870,0.00020737403238288454,0.0029051216718365917,0.002186853432401328,APOA4/APOC1/APOC2/APOC3/IGF1/IGFBP3/MST1,7,,
GO:0015748,C4,GO:0015748,organophosphate ester transport,5/68,152/18870,0.00021995874518162615,0.0030536614984223954,0.002298667967663841,APOA2/APOA4/APOC1/APOC2/APOC3,5,,
GO:0016125,C4,GO:0016125,sterol metabolic process,5/68,154/18870,0.00023372151256076067,0.003215757596929752,0.0024206870943793072,APOA2/APOA4/APOC1/APOL1/PON1,5,,
GO:0002443,C4,GO:0002443,leukocyte mediated immunity,8/68,466/18870,0.0002628647920898792,0.0035847313682345473,0.002698435033843008,C1QC/C4A/C4B/C6/CLU/DBH/F2/TFRC,8,,
GO:0010984,C4,GO:0010984,regulation of lipoprotein particle clearance,3/68,36/18870,0.00029347974516994666,0.003967125327253402,0.0029862851262906854,APOC1/APOC2/APOC3,3,,
GO:0048261,C4,GO:0048261,negative regulation of receptor-mediated endocytosis,3/68,37/18870,0.0003185533983685331,0.004268615538138344,0.0032132342791956385,APOC1/APOC2/APOC3,3,,
GO:0045785,C4,GO:0045785,positive regulation of cell adhesion,8/68,482/18870,0.0003297303570582519,0.004380297243334191,0.0032973035705825193,CDH13/DPP4/FN1/HRG/IGF1/PTPRJ/TFRC/VTN,8,,
GO:0006066,C4,GO:0006066,alcohol metabolic process,7/68,373/18870,0.0003834438551677556,0.005050316075329157,0.0038016655726033893,APOA2/APOA4/APOC1/APOL1/DBH/IGF1/PON1,7,,
GO:0055088,C4,GO:0055088,lipid homeostasis,5/68,175/18870,0.0004211871277987199,0.005500418338456164,0.004140483629207756,APOA2/APOA4/APOC2/APOC3/APOC4,5,,
GO:0019217,C4,GO:0019217,regulation of fatty acid metabolic process,4/68,100/18870,0.00046622973716046117,0.0059871668747022554,0.004506887459217792,APOA4/APOC1/APOC2/APOC3,4,,
GO:0042632,C4,GO:0042632,cholesterol homeostasis,4/68,100/18870,0.00046622973716046117,0.0059871668747022554,0.004506887459217792,APOA2/APOA4/APOC2/APOC3,4,,
GO:0055092,C4,GO:0055092,sterol homeostasis,4/68,101/18870,0.0004841475341686088,0.006165878926891126,0.004641414377153606,APOA2/APOA4/APOC2/APOC3,4,,
GO:0090207,C4,GO:0090207,regulation of triglyceride metabolic process,3/68,44/18870,0.0005332781182328743,0.006735914591777536,0.005070513255328969,APOA4/APOC2/APOC3,3,,
GO:1904729,C4,GO:1904729,regulation of intestinal lipid absorption,2/68,10/18870,0.0005651594636566494,0.006967285867959173,0.005244679822733706,APOA2/APOA4,2,,
GO:1905918,C4,GO:1905918,regulation of CoA-transferase activity,2/68,10/18870,0.0005651594636566494,0.006967285867959173,0.005244679822733706,APOA2/APOA4,2,,
GO:2000425,C4,GO:2000425,regulation of apoptotic cell clearance,2/68,10/18870,0.0005651594636566494,0.006967285867959173,0.005244679822733706,C4A/C4B,2,,
GO:0002526,C4,GO:0002526,acute inflammatory response,4/68,107/18870,0.000602112974720795,0.007363937254323373,0.005543262306953352,F2/FN1/KLKB1/TFRC,4,,
GO:0006953,C4,GO:0006953,acute-phase response,3/68,48/18870,0.0006893047348157967,0.00836392595552081,0.006296011751073419,F2/FN1/TFRC,3,,
GO:0045833,C4,GO:0045833,negative regulation of lipid metabolic process,4/68,112/18870,0.0007149416946835966,0.008607227746151738,0.006479159108070095,APOA2/APOC1/APOC2/APOC3,4,,
GO:0035987,C4,GO:0035987,endodermal cell differentiation,3/68,49/18870,0.0007323735328902527,0.008748741195223871,0.006585684481803823,COL6A1/FN1/VTN,3,,
GO:0007626,C4,GO:0007626,locomotory behavior,5/68,201/18870,0.0007893865771212565,0.009357267041106588,0.007043757149697366,CNTN1/DBH/DPP4/NAGLU/SELENOP,5,,
GO:0034379,C4,GO:0034379,very-low-density lipoprotein particle assembly,2/68,12/18870,0.0008250473781758258,0.00963180310431021,0.007250416353666349,APOC1/APOC3,2,,
GO:1904478,C4,GO:1904478,regulation of intestinal absorption,2/68,12/18870,0.0008250473781758258,0.00963180310431021,0.007250416353666349,APOA2/APOA4,2,,
GO:0010823,C4,GO:0010823,negative regulation of mitochondrion organization,3/68,52/18870,0.0008717486905286395,0.010100486707553634,0.007603221661753547,CLU/IGF1/TFRC,3,,
GO:0043568,C4,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2/68,13/18870,0.000972787931014123,0.011111105410919185,0.00836397292450763,IGF1/IGFBP3,2,,
GO:0009395,C4,GO:0009395,phospholipid catabolic process,3/68,54/18870,0.0009733934006970085,0.011111105410919185,0.00836397292450763,APOA2/APOC1/APOC2,3,,
GO:0001954,C4,GO:0001954,positive regulation of cell-matrix adhesion,3/68,56/18870,0.0010822514147253895,0.012262863456557537,0.009230967949128322,CDH13/HRG/PTPRJ,3,,
GO:0050821,C4,GO:0050821,protein stabilization,5/68,217/18870,0.0011117831798872458,0.012505531972308364,0.009413638603424855,AFM/APOA2/CLU/IGF1/LAMP2,5,,
GO:0051384,C4,GO:0051384,response to glucocorticoid,4/68,127/18870,0.0011425222451308423,0.012728358726339718,0.009581373213857285,APOA2/BCHE/CPN1/SERPINF1,4,,
GO:0008202,C4,GO:0008202,steroid metabolic process,6/68,327/18870,0.001148112824763933,0.012728358726339718,0.009581373213857285,APOA2/APOA4/APOC1/APOL1/PON1/SERPINA6,6,,
GO:0001706,C4,GO:0001706,endoderm formation,3/68,58/18870,0.0011985149101616489,0.013192224832565007,0.009930552112767948,COL6A1/FN1/VTN,3,,
GO:0061684,C4,GO:0061684,chaperone-mediated autophagy,2/68,15/18870,0.001303439510346901,0.01424539209535159,0.01072333214186103,CLU/LAMP2,2,,
GO:0019216,C4,GO:0019216,regulation of lipid metabolic process,6/68,342/18870,0.0014437087499737694,0.015667290026123794,0.01179367711246178,APOA2/APOA4/APOC1/APOC2/APOC3/F2,6,,
GO:0072378,C4,GO:0072378,"blood coagulation, fibrin clot formation",2/68,16/18870,0.0014861827688420922,0.01601543808941024,0.012055748334663125,F13A1/F13B,2,,
GO:0006909,C4,GO:0006909,phagocytosis,5/68,237/18870,0.001641308250073298,0.01756427787057606,0.013221649792257125,APOA2/C4A/C4B/CFP/PTPRJ,5,,
GO:0008228,C4,GO:0008228,opsonization,2/68,17/18870,0.0016804265560127114,0.017858878088383368,0.013443412448101693,C4B/CFP,2,,
GO:0007160,C4,GO:0007160,cell-matrix adhesion,5/68,239/18870,0.0017029271565827259,0.01797404622119165,0.013530106175588783,CDH13/FN1/HRG/PTPRJ/VTN,5,,
GO:0031589,C4,GO:0031589,cell-substrate adhesion,6/68,356/18870,0.0017690726237962848,0.01854517628074881,0.013960028868052315,CDH13/FN1/HRG/PLG/PTPRJ/VTN,6,,
GO:0010565,C4,GO:0010565,regulation of cellular ketone metabolic process,4/68,144/18870,0.0018142559876414461,0.018804797600447506,0.01415546088028495,APOA4/APOC1/APOC2/APOC3,4,,
GO:0070613,C4,GO:0070613,regulation of protein processing,3/68,67/18870,0.0018182445441055667,0.018804797600447506,0.01415546088028495,CLEC3B/CPB2/KLKB1,3,,
GO:0045834,C4,GO:0045834,positive regulation of lipid metabolic process,4/68,145/18870,0.0018607144300980447,0.01911573957854058,0.014389524926091548,APOA2/APOA4/APOC2/F2,4,,
GO:0010755,C4,GO:0010755,regulation of plasminogen activation,2/68,18/18870,0.001886088077066274,0.019121458728678476,0.014393830061821567,CLEC3B/CPB2,2,,
GO:0030299,C4,GO:0030299,intestinal cholesterol absorption,2/68,18/18870,0.001886088077066274,0.019121458728678476,0.014393830061821567,APOA2/APOA4,2,,
GO:0046434,C4,GO:0046434,organophosphate catabolic process,4/68,146/18870,0.0019079922443589296,0.019217098356582422,0.014465823552002344,APOA2/APOC1/APOC2/PON1,4,,
GO:0050918,C4,GO:0050918,positive chemotaxis,3/68,69/18870,0.0019784510186694913,0.019797357271231726,0.014902618062705262,CDH13/F7/PTPRJ,3,,
GO:0031960,C4,GO:0031960,response to corticosteroid,4/68,149/18870,0.0020548166625036853,0.020428854689794704,0.015377982764543711,APOA2/BCHE/CPN1/SERPINF1,4,,
GO:0002449,C4,GO:0002449,lymphocyte mediated immunity,6/68,368/18870,0.002089970110495618,0.02064515346329325,0.015540803385736646,C1QC/C4A/C4B/C6/CLU/TFRC,6,,
GO:0010001,C4,GO:0010001,glial cell differentiation,5/68,252/18870,0.00214576726483265,0.02094191785937729,0.015764195143982904,CLU/CNTN1/F2/NAGLU/VTN,5,,
GO:1903317,C4,GO:1903317,regulation of protein maturation,3/68,71/18870,0.0021471920971976714,0.02094191785937729,0.015764195143982904,CLEC3B/CPB2/KLKB1,3,,
GO:0006879,C4,GO:0006879,intracellular iron ion homeostasis,3/68,73/18870,0.0023246237829205717,0.022453673111024048,0.016902180927182285,NAGLU/NEO1/TFRC,3,,
GO:0090201,C4,GO:0090201,negative regulation of release of cytochrome c from mitochondria,2/68,20/18870,0.0023313353003010045,0.022453673111024048,0.016902180927182285,CLU/IGF1,2,,
GO:0002460,C4,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6/68,380/18870,0.0024531787105555687,0.023480424801031873,0.017675076423878635,C1QC/C4A/C4B/C6/CLU/TFRC,6,,
GO:0045806,C4,GO:0045806,negative regulation of endocytosis,3/68,75/18870,0.0025108975536798045,0.023884525495188755,0.017979266433756625,APOC1/APOC2/APOC3,3,,
GO:0046486,C4,GO:0046486,glycerolipid metabolic process,6/68,390/18870,0.002790645598898529,0.026190229694006938,0.019714903598343964,APOA2/APOA4/APOC1/APOC2/APOC3/PON1,6,,
GO:0044241,C4,GO:0044241,lipid digestion,2/68,22/18870,0.002821270687349222,0.026190229694006938,0.019714903598343964,APOA2/APOA4,2,,
GO:0090208,C4,GO:0090208,positive regulation of triglyceride metabolic process,2/68,22/18870,0.002821270687349222,0.026190229694006938,0.019714903598343964,APOA4/APOC2,2,,
GO:0098856,C4,GO:0098856,intestinal lipid absorption,2/68,22/18870,0.002821270687349222,0.026190229694006938,0.019714903598343964,APOA2/APOA4,2,,
GO:0061744,C4,GO:0061744,motor behavior,2/68,23/18870,0.0030827940116246086,0.02844662019109893,0.02141341948194339,DPP4/NAGLU,2,,
GO:0006633,C4,GO:0006633,fatty acid biosynthetic process,4/68,168/18870,0.0031703839618268358,0.029080724316518772,0.02189074640309006,APOA4/APOC1/APOC2/APOC3,4,,
GO:0150076,C4,GO:0150076,neuroinflammatory response,3/68,82/18870,0.0032345703271870587,0.029493922332516315,0.02220178449430171,CLU/IGF1/NAGLU,3,,
GO:0007492,C4,GO:0007492,endoderm development,3/68,83/18870,0.0033472884146196857,0.02974430827867792,0.02239026450568877,COL6A1/FN1/VTN,3,,
GO:0061844,C4,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3/68,83/18870,0.0033472884146196857,0.02974430827867792,0.02239026450568877,CAMP/F2/HRG,3,,
GO:0010640,C4,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,2/68,24/18870,0.003355247307118873,0.02974430827867792,0.02239026450568877,F7/PTPRJ,2,,
GO:0045723,C4,GO:0045723,positive regulation of fatty acid biosynthetic process,2/68,24/18870,0.003355247307118873,0.02974430827867792,0.02239026450568877,APOA4/APOC2,2,,
GO:0048660,C4,GO:0048660,regulation of smooth muscle cell proliferation,4/68,171/18870,0.003377841628013391,0.02974430827867792,0.02239026450568877,CDH13/DBH/IGF1/IGFBP3,4,,
GO:0051897,C4,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,4/68,171/18870,0.003377841628013391,0.02974430827867792,0.02239026450568877,F7/FN1/IGF1/PTPRJ,4,,
GO:0043542,C4,GO:0043542,endothelial cell migration,5/68,284/18870,0.003587894287820595,0.03115003736478665,0.02344843824993674,CDH13/DPP4/HRG/PLG/SERPINF1,5,,
GO:0010954,C4,GO:0010954,positive regulation of protein processing,2/68,25/18870,0.003638550762921218,0.03115003736478665,0.02344843824993674,CLEC3B/KLKB1,2,,
GO:0043567,C4,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,2/68,25/18870,0.003638550762921218,0.03115003736478665,0.02344843824993674,IGF1/IGFBP3,2,,
GO:0050927,C4,GO:0050927,positive regulation of positive chemotaxis,2/68,25/18870,0.003638550762921218,0.03115003736478665,0.02344843824993674,CDH13/F7,2,,
GO:0060586,C4,GO:0060586,multicellular organismal-level iron ion homeostasis,2/68,25/18870,0.003638550762921218,0.03115003736478665,0.02344843824993674,NAGLU/NEO1,2,,
GO:0048659,C4,GO:0048659,smooth muscle cell proliferation,4/68,175/18870,0.0036686005733638197,0.03123377615223009,0.023511473287856525,CDH13/DBH/IGF1/IGFBP3,4,,
GO:0052548,C4,GO:0052548,regulation of endopeptidase activity,5/68,288/18870,0.003807523185382414,0.03223842433337527,0.024267730192547254,HRG/SERPINA5/SERPINA6/SERPINF1/VTN,5,,
GO:0001558,C4,GO:0001558,regulation of cell growth,6/68,417/18870,0.0038763864248611817,0.032525360145650904,0.02448372340620055,F2/FN1/HRG/IGF1/IGFBP3/PTPRJ,6,,
GO:0045717,C4,GO:0045717,negative regulation of fatty acid biosynthetic process,2/68,26/18870,0.003932624986660521,0.032525360145650904,0.02448372340620055,APOC1/APOC3,2,,
GO:0050926,C4,GO:0050926,regulation of positive chemotaxis,2/68,26/18870,0.003932624986660521,0.032525360145650904,0.02448372340620055,CDH13/F7,2,,
GO:0051894,C4,GO:0051894,positive regulation of focal adhesion assembly,2/68,26/18870,0.003932624986660521,0.032525360145650904,0.02448372340620055,HRG/PTPRJ,2,,
GO:0033627,C4,GO:0033627,cell adhesion mediated by integrin,3/68,88/18870,0.003946945066344399,0.032525360145650904,0.02448372340620055,DPP4/HRG/VTN,3,,
GO:0014910,C4,GO:0014910,regulation of smooth muscle cell migration,3/68,89/18870,0.004074196971701819,0.03339541241166225,0.02513866216581974,IGF1/IGFBP3/VTN,3,,
GO:0022010,C4,GO:0022010,central nervous system myelination,2/68,27/18870,0.004237391002597237,0.03400947674480386,0.025600903974024973,CLU/CNTN1,2,,
GO:0032291,C4,GO:0032291,axon ensheathment in central nervous system,2/68,27/18870,0.004237391002597237,0.03400947674480386,0.025600903974024973,CLU/CNTN1,2,,
GO:0042133,C4,GO:0042133,neurotransmitter metabolic process,2/68,27/18870,0.004237391002597237,0.03400947674480386,0.025600903974024973,BCHE/DBH,2,,
GO:1903319,C4,GO:1903319,positive regulation of protein maturation,2/68,27/18870,0.004237391002597237,0.03400947674480386,0.025600903974024973,CLEC3B/KLKB1,2,,
GO:0048771,C4,GO:0048771,tissue remodeling,4/68,184/18870,0.004384085902254415,0.035004540805046905,0.026349946355518766,DBH/HRG/PLG/TFRC,4,,
GO:0002227,C4,GO:0002227,innate immune response in mucosa,2/68,28/18870,0.004552770249723451,0.03597855874268635,0.027083146100918994,APOA4/CAMP,2,,
GO:0018149,C4,GO:0018149,peptide cross-linking,2/68,28/18870,0.004552770249723451,0.03597855874268635,0.027083146100918994,F13A1/FN1,2,,
GO:0097696,C4,GO:0097696,receptor signaling pathway via STAT,4/68,188/18870,0.004730312926103786,0.03719087866900987,0.027995729562655065,F2/IGF1/MST1/NAGLU,4,,
GO:0046890,C4,GO:0046890,regulation of lipid biosynthetic process,4/68,189/18870,0.004819662114592671,0.037491320623162114,0.02822188963197148,APOA4/APOC1/APOC2/APOC3,4,,
GO:0006910,C4,GO:0006910,"phagocytosis, recognition",2/68,29/18870,0.00487868457987078,0.037491320623162114,0.02822188963197148,C4B/CFP,2,,
GO:0097421,C4,GO:0097421,liver regeneration,2/68,29/18870,0.00487868457987078,0.037491320623162114,0.02822188963197148,CPB2/VTN,2,,
GO:1902430,C4,GO:1902430,negative regulation of amyloid-beta formation,2/68,29/18870,0.00487868457987078,0.037491320623162114,0.02822188963197148,CLU/IGF1,2,,
GO:0007044,C4,GO:0007044,cell-substrate junction assembly,3/68,95/18870,0.004890172255195058,0.037491320623162114,0.02822188963197148,FN1/HRG/PTPRJ,3,,
GO:0014909,C4,GO:0014909,smooth muscle cell migration,3/68,96/18870,0.005035040236326993,0.03822166011911279,0.028771658493297103,IGF1/IGFBP3/VTN,3,,
GO:0042982,C4,GO:0042982,amyloid precursor protein metabolic process,3/68,96/18870,0.005035040236326993,0.03822166011911279,0.028771658493297103,CLU/IGF1/NAGLU,3,,
GO:0035640,C4,GO:0035640,exploration behavior,2/68,30/18870,0.005215056255826279,0.03939412593249164,0.029654241454698447,DPP4/NAGLU,2,,
GO:0052547,C4,GO:0052547,regulation of peptidase activity,5/68,312/18870,0.005332756108192052,0.040086717866946106,0.030175595539037953,HRG/SERPINA5/SERPINA6/SERPINF1/VTN,5,,
GO:0150117,C4,GO:0150117,positive regulation of cell-substrate junction organization,2/68,31/18870,0.005561807949456204,0.0416055633500583,0.0313189185503359,HRG/PTPRJ,2,,
GO:1902992,C4,GO:1902992,negative regulation of amyloid precursor protein catabolic process,2/68,32/18870,0.005918862739837786,0.04406264484101463,0.03316850617493639,CLU/IGF1,2,,
GO:0150115,C4,GO:0150115,cell-substrate junction organization,3/68,102/18870,0.005958654400912262,0.04414560784522017,0.03323095723585685,FN1/HRG/PTPRJ,3,,
GO:0030198,C4,GO:0030198,extracellular matrix organization,5/68,321/18870,0.006002819252961774,0.04426002138188562,0.03331708293509884,CPB2/DPP4/PLG/QSOX1/VTN,5,,
GO:0043062,C4,GO:0043062,extracellular structure organization,5/68,322/18870,0.0060807700557299945,0.04462126978990438,0.033589015545937115,CPB2/DPP4/PLG/QSOX1/VTN,5,,
GO:0010906,C4,GO:0010906,regulation of glucose metabolic process,3/68,103/18870,0.006121770616367065,0.04470923469109785,0.033655231824577234,IGF1/IGFBP3/MST1,3,,
GO:0045229,C4,GO:0045229,external encapsulating structure organization,5/68,323/18870,0.0061594332742147765,0.044772106960212124,0.03370255942494878,CPB2/DPP4/PLG/QSOX1/VTN,5,,
GO:0006622,C4,GO:0006622,protein targeting to lysosome,2/68,33/18870,0.006286144111398664,0.04527616932761564,0.03408199637899685,CLU/LAMP2,2,,
GO:0021549,C4,GO:0021549,cerebellum development,3/68,104/18870,0.006287540711297695,0.04527616932761564,0.03408199637899685,ATRN/CNTN1/NAGLU,3,,
GO:0031647,C4,GO:0031647,regulation of protein stability,5/68,325/18870,0.006318910572939558,0.045290424153022604,0.03409272681213902,AFM/APOA2/CLU/IGF1/LAMP2,5,,
GO:0032963,C4,GO:0032963,collagen metabolic process,3/68,106/18870,0.006627086626081614,0.046845598581613614,0.03526339672593887,F2/NAGLU/PEPD,3,,
GO:0048709,C4,GO:0048709,oligodendrocyte differentiation,3/68,106/18870,0.006627086626081614,0.046845598581613614,0.03526339672593887,CLU/CNTN1/VTN,3,,
GO:1901890,C4,GO:1901890,positive regulation of cell junction assembly,3/68,106/18870,0.006627086626081614,0.046845598581613614,0.03526339672593887,HRG/IL1RAP/PTPRJ,3,,
GO:1903725,C4,GO:1903725,regulation of phospholipid metabolic process,2/68,35/18870,0.007051082551413018,0.04961515165172357,0.037348199815703656,APOC1/APOC2,2,,
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,C5,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,6/41,49/4383,4.765422570277103e-06,0.0001667897899596986,0.00013042209139705756,CAT/GPX3/MPO/PRDX2/SOD1/TXN,6,,
HALLMARK_GLYCOLYSIS,C5,HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,7/41,200/4383,0.0022197604475411113,0.025897205221312964,0.02025044618809435,ALDOB/HSPA5/LDHA/PPIA/SOD1/TALDO1/TXN,7,,
HALLMARK_HEME_METABOLISM,C5,HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,7/41,200/4383,0.0022197604475411113,0.025897205221312964,0.02025044618809435,BLVRB/CA1/CA2/CAT/HBB/PRDX2/SELENBP1,7,,
hsa04610,C5,hsa04610,Complement and coagulation cascades,6/46,88/8843,5.565240313311546e-06,0.0005954807135243354,0.0004920844066507051,CFD/CFHR3/F10/F12/PROCR/SERPINC1,6,Organismal Systems,Immune system
hsa04612,C5,hsa04612,Antigen processing and presentation,4/46,80/8843,0.0007594512700330564,0.04063064294676852,0.033575740359356177,CALR/HLA-A/HSPA5/PDIA3,4,Organismal Systems,Immune system
R-HSA-9020591,C5,R-HSA-9020591,Interleukin-12 signaling,7/57,47/11009,3.652701589144229e-09,7.780254384877208e-07,6.382615408399391e-07,CA1/CFL1/MSN/P4HB/PPIA/SOD1/TALDO1,7,,
R-HSA-447115,C5,R-HSA-447115,Interleukin-12 family signaling,7/57,57/11009,1.4755150671909528e-08,1.2496614769380963e-06,1.025173240285268e-06,CA1/CFL1/MSN/P4HB/PPIA/SOD1/TALDO1,7,,
R-HSA-114608,C5,R-HSA-114608,Platelet degranulation,9/57,129/11009,1.7600865872367554e-08,1.2496614769380963e-06,1.025173240285268e-06,APOH/CFD/CFL1/ECM1/HSPA5/PFN1/PPIA/SERPINA4/SOD1,9,,
R-HSA-76005,C5,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,9/57,134/11009,2.4564585695311676e-08,1.2680253381002008e-06,1.0402382314041676e-06,APOH/CFD/CFL1/ECM1/HSPA5/PFN1/PPIA/SERPINA4/SOD1,9,,
R-HSA-3299685,C5,R-HSA-3299685,Detoxification of Reactive Oxygen Species,6/57,37/11009,3.0199139013822273e-08,1.2680253381002008e-06,1.0402382314041676e-06,CAT/GPX3/P4HB/PRDX2/SOD1/TXN,6,,
R-HSA-8950505,C5,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,6/57,38/11009,3.571902360845636e-08,1.2680253381002008e-06,1.0402382314041676e-06,CA1/CFL1/MSN/PPIA/SOD1/TALDO1,6,,
R-HSA-9711123,C5,R-HSA-9711123,Cellular response to chemical stress,10/57,215/11009,1.2689658226402964e-07,3.861281717462616e-06,3.1676440083953263e-06,BLVRB/CAT/GPX3/HBA1/HBB/P4HB/PRDX2/SOD1/TALDO1/TXN,10,,
R-HSA-1237044,C5,R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,4/57,13/11009,4.4595135950803104e-07,1.0554182175023403e-05,8.658236921442474e-06,CA1/CA2/HBA1/HBB,4,,
R-HSA-1480926,C5,R-HSA-1480926,O2/CO2 exchange in erythrocytes,4/57,13/11009,4.4595135950803104e-07,1.0554182175023403e-05,8.658236921442474e-06,CA1/CA2/HBA1/HBB,4,,
R-HSA-6798695,C5,R-HSA-6798695,Neutrophil degranulation,13/57,480/11009,7.374091575918503e-07,1.570681505670641e-05,1.2885254753710228e-05,ANPEP/CAT/CEACAM8/CFD/FUCA2/HBB/KRT1/MANBA/MPO/PNP/PPIA/PRSS3/SELL,13,,
R-HSA-76002,C5,R-HSA-76002,"Platelet activation, signaling and aggregation",9/57,263/11009,7.294195089870649e-06,0.00014124214128567711,0.00011586951051851941,APOH/CFD/CFL1/ECM1/HSPA5/PFN1/PPIA/SERPINA4/SOD1,9,,
R-HSA-983170,C5,R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",4/57,29/11009,1.3927664334338785e-05,0.00024721604193451345,0.0002028063403070385,CALR/HLA-A/HSPA5/PDIA3,4,,
R-HSA-2168880,C5,R-HSA-2168880,Scavenging of heme from plasma,3/57,13/11009,3.6280080330775064e-05,0.0005944351623426991,0.00048765128217883897,HBA1/HBB/HPX,3,,
R-HSA-140877,C5,R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),4/57,39/11009,4.641052508574269e-05,0.0007061029888045138,0.0005792591852806984,F10/F12/PROCR/SERPINC1,4,,
R-HSA-2173782,C5,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,4/57,42/11009,6.24321749403635e-05,0.0008865368841531615,0.0007272800729894977,CALR/HBA1/HBB/HPX,4,,
R-HSA-140875,C5,R-HSA-140875,Common Pathway of Fibrin Clot Formation,3/57,22/11009,0.00018899433093966472,0.0025159870306342867,0.0020640170352621283,F10/PROCR/SERPINC1,3,,
R-HSA-140837,C5,R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/57,23/11009,0.0002165463744508165,0.0027131986916484655,0.002225801743581148,F10/F12/SERPINC1,3,,
R-HSA-1474244,C5,R-HSA-1474244,Extracellular matrix organization,7/57,300/11009,0.0008554766322233136,0.010123140147975879,0.00830462695608597,CEACAM8/COL18A1/LUM/NCAM1/P4HB/PCOLCE/PRSS1,7,,
R-HSA-381183,C5,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,2/57,10/11009,0.0011540914165135148,0.012291073585868933,0.010083114481118078,CALR/HSPA5,2,,
R-HSA-9758881,C5,R-HSA-9758881,Uptake of dietary cobalamins into enterocytes,2/57,10/11009,0.0011540914165135148,0.012291073585868933,0.010083114481118078,PRSS1/PRSS3,2,,
R-HSA-1475029,C5,R-HSA-1475029,Reversible hydration of carbon dioxide,2/57,12/11009,0.0016814424825836597,0.016279420399559978,0.013354997708559213,CA1/CA2,2,,
R-HSA-381033,C5,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,2/57,12/11009,0.0016814424825836597,0.016279420399559978,0.013354997708559213,CALR/HSPA5,2,,
R-HSA-449147,C5,R-HSA-449147,Signaling by Interleukins,8/57,473/11009,0.002834770194456415,0.025703120241150203,0.02108583128258431,CA1/CFL1/CSF1R/MSN/P4HB/PPIA/SOD1/TALDO1,8,,
R-HSA-9651496,C5,R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/57,16/11009,0.0030167981503697425,0.025703120241150203,0.02108583128258431,F10/F12,2,,
R-HSA-9671793,C5,R-HSA-9671793,Diseases of hemostasis,2/57,16/11009,0.0030167981503697425,0.025703120241150203,0.02108583128258431,F10/F12,2,,
R-HSA-166658,C5,R-HSA-166658,Complement cascade,3/57,58/11009,0.0033189948037999364,0.027190226661899478,0.022305795037683783,CFD/CFHR3/FCN3,3,,
R-HSA-381426,C5,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),4/57,125/11009,0.0039330582384231715,0.031027459436449467,0.025453710236968675,FUCA2/IGFBP6/P4HB/SERPINC1,4,,
R-HSA-9707564,C5,R-HSA-9707564,Cytoprotection by HMOX1,3/57,64/11009,0.0043845194807696835,0.033353666050140805,0.027362038864953666,BLVRB/HBA1/HBB,3,,
R-HSA-1650814,C5,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,3/57,67/11009,0.004986468234079711,0.036624749443413054,0.030045507326941272,COL18A1/P4HB/PCOLCE,3,,
R-HSA-202733,C5,R-HSA-202733,Cell surface interactions at the vascular wall,4/57,137/11009,0.0054445593835420044,0.03865637162314823,0.031712170444490276,CEACAM8/PPIA/PROCR/SELL,4,,
R-HSA-196741,C5,R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",2/57,22/11009,0.0056928907319764585,0.03911566857777373,0.03208895964373828,PRSS1/PRSS3,2,,
R-HSA-166663,C5,R-HSA-166663,Initial triggering of complement,2/57,23/11009,0.006214447337455095,0.04136491508993548,0.03393415322426138,CFD/FCN3,2,,
GO:0042743,C5,GO:0042743,hydrogen peroxide metabolic process,8/65,54/18870,1.1655520968023129e-11,1.6807261235889352e-08,1.4305618367068386e-08,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:0007596,C5,GO:0007596,blood coagulation,11/65,224/18870,2.631013822866131e-10,1.3162094869259505e-07,1.1203009429561707e-07,ADAMTS13/APOH/F10/F12/HBB/KRT1/PDIA3/PPIA/PRDX2/PROCR/SERPINC1,11,,
GO:0050817,C5,GO:0050817,coagulation,11/65,229/18870,3.3284682384352226e-10,1.3162094869259505e-07,1.1203009429561707e-07,ADAMTS13/APOH/F10/F12/HBB/KRT1/PDIA3/PPIA/PRDX2/PROCR/SERPINC1,11,,
GO:0007599,C5,GO:0007599,hemostasis,11/65,231/18870,3.651066537936063e-10,1.3162094869259505e-07,1.1203009429561707e-07,ADAMTS13/APOH/F10/F12/HBB/KRT1/PDIA3/PPIA/PRDX2/PROCR/SERPINC1,11,,
GO:0042744,C5,GO:0042744,hydrogen peroxide catabolic process,6/65,31/18870,9.076566841221976e-10,2.6176818770084177e-07,2.2280583024978574e-07,CAT/GPX3/HBA1/HBB/MPO/PRDX2,6,,
GO:0098869,C5,GO:0098869,cellular oxidant detoxification,8/65,99/18870,1.6990051558686188e-09,4.0832757246042475e-07,3.4755087925312444e-07,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:1990748,C5,GO:1990748,cellular detoxification,8/65,119/18870,7.374731649851552e-09,1.5191947198694198e-06,1.2930732486807383e-06,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:0097237,C5,GO:0097237,cellular response to toxic substance,8/65,128/18870,1.312234262271302e-08,2.365302257744022e-06,2.013243618168866e-06,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:0042060,C5,GO:0042060,wound healing,12/65,423/18870,1.8976096302609546e-08,3.0403923187069964e-06,2.587851261852951e-06,ADAMTS13/APOH/F10/F12/HBB/KRT1/MCAM/PDIA3/PPIA/PRDX2/PROCR/SERPINC1,12,,
GO:0034975,C5,GO:0034975,protein folding in endoplasmic reticulum,4/65,11/18870,4.1544900001449585e-08,5.625583205917834e-06,4.7882546303381215e-06,CALR/HSPA5/P4HB/PDIA3,4,,
GO:0050878,C5,GO:0050878,regulation of body fluid levels,11/65,365/18870,4.291360281906808e-08,5.625583205917834e-06,4.7882546303381215e-06,ADAMTS13/APOH/F10/F12/HBB/KRT1/PDIA3/PPIA/PRDX2/PROCR/SERPINC1,11,,
GO:0098754,C5,GO:0098754,detoxification,8/65,158/18870,6.810607880280691e-08,8.18408046947063e-06,6.965937533690601e-06,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:0050818,C5,GO:0050818,regulation of coagulation,6/65,73/18870,1.8748802971368306e-07,2.0796749142086996e-05,1.770129899968862e-05,APOH/F12/KRT1/PRDX2/PROCR/SERPINC1,6,,
GO:0009636,C5,GO:0009636,response to toxic substance,9/65,258/18870,2.3812738133796896e-07,2.4527120277810804e-05,2.087643057444149e-05,ADAMTS13/CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,9,,
GO:0006979,C5,GO:0006979,response to oxidative stress,10/65,400/18870,1.0368741323507641e-06,9.96781665899868e-05,8.484177111024498e-05,CAT/GPX3/HBA1/HBB/KRT1/MPO/PPIA/PRDX2/SOD1/TXN,10,,
GO:0072593,C5,GO:0072593,reactive oxygen species metabolic process,8/65,234/18870,1.3625505817754547e-06,0.00012279987118251286,0.00010452197225988028,CAT/GPX3/HBA1/HBB/MPO/PRDX2/SOD1/TXN,8,,
GO:0030193,C5,GO:0030193,regulation of blood coagulation,5/65,68/18870,3.6561510082874364e-06,0.00031012763258532255,0.0002639673111865728,APOH/F12/KRT1/PRDX2/SERPINC1,5,,
GO:1900046,C5,GO:1900046,regulation of hemostasis,5/65,70/18870,4.222576008703713e-06,0.0003382752558083752,0.00028792535825429994,APOH/F12/KRT1/PRDX2/SERPINC1,5,,
GO:0000302,C5,GO:0000302,response to reactive oxygen species,7/65,205/18870,6.58259167302656e-06,0.0004995840627633842,0.0004252244814819373,CAT/HBA1/HBB/MPO/PRDX2/SOD1/TXN,7,,
GO:0044403,C5,GO:0044403,biological process involved in symbiotic interaction,8/65,322/18870,1.4283358436735795e-05,0.0010298301432886507,0.0008765471545912597,ANPEP/CFL1/CSF1R/FCN3/FUCA2/NCAM1/P4HB/PPIA,8,,
GO:0015670,C5,GO:0015670,carbon dioxide transport,3/65,15/18870,1.7232449273506937e-05,0.001183294850114143,0.0010071697169377989,CA2/HBA1/HBB,3,,
GO:0042542,C5,GO:0042542,response to hydrogen peroxide,5/65,101/18870,2.5457780929375e-05,0.0016686418227344886,0.001420276199217763,CAT/HBA1/HBB/SOD1/TXN,5,,
GO:0006959,C5,GO:0006959,humoral immune response,7/65,258/18870,2.915725402658434e-05,0.0018280330567971574,0.0015559431668191002,CFD/CFHR3/FCN3/HLA-A/HPX/KRT1/PRSS3,7,,
GO:0050819,C5,GO:0050819,negative regulation of coagulation,4/65,52/18870,3.0654582401855016e-05,0.001841829492644789,0.0015676861000246908,APOH/F12/KRT1/PROCR,4,,
GO:0044000,C5,GO:0044000,movement in host,6/65,188/18870,4.57813147809916e-05,0.0026406662365675952,0.002247621601458366,ANPEP/FCN3/FUCA2/NCAM1/P4HB/PPIA,6,,
GO:0015669,C5,GO:0015669,gas transport,3/65,22/18870,5.732820820312568e-05,0.0031795106241887397,0.0027062627840018032,CA2/HBA1/HBB,3,,
GO:0019430,C5,GO:0019430,removal of superoxide radicals,3/65,23/18870,6.576533438739403e-05,0.0035123560069119327,0.002989566467668672,MPO/PRDX2/SOD1,3,,
GO:0006956,C5,GO:0006956,complement activation,4/65,67/18870,8.3494308545283e-05,0.004037782325490928,0.0034367867665686704,CFD/CFHR3/FCN3/KRT1,4,,
GO:0071450,C5,GO:0071450,cellular response to oxygen radical,3/65,25/18870,8.499010334351605e-05,0.004037782325490928,0.0034367867665686704,MPO/PRDX2/SOD1,3,,
GO:0071451,C5,GO:0071451,cellular response to superoxide,3/65,25/18870,8.499010334351605e-05,0.004037782325490928,0.0034367867665686704,MPO/PRDX2/SOD1,3,,
GO:0051701,C5,GO:0051701,biological process involved in interaction with host,6/65,211/18870,8.6803919618737e-05,0.004037782325490928,0.0034367867665686704,ANPEP/FCN3/FUCA2/NCAM1/P4HB/PPIA,6,,
GO:0061041,C5,GO:0061041,regulation of wound healing,5/65,133/18870,9.491868800487447e-05,0.004277273378219656,0.003640631257029067,APOH/F12/KRT1/PRDX2/SERPINC1,5,,
GO:0042730,C5,GO:0042730,fibrinolysis,3/65,27/18870,0.00010755459708041134,0.0046998099693925195,0.004000276242288984,APOH/F12/KRT1,3,,
GO:0000303,C5,GO:0000303,response to superoxide,3/65,28/18870,0.00012016513941747462,0.004813281417777733,0.004096858262010976,MPO/PRDX2/SOD1,3,,
GO:0030194,C5,GO:0030194,positive regulation of blood coagulation,3/65,28/18870,0.00012016513941747462,0.004813281417777733,0.004096858262010976,APOH/F12/PRDX2,3,,
GO:1900048,C5,GO:1900048,positive regulation of hemostasis,3/65,28/18870,0.00012016513941747462,0.004813281417777733,0.004096858262010976,APOH/F12/PRDX2,3,,
GO:0000305,C5,GO:0000305,response to oxygen radical,3/65,29/18870,0.00013370103627335605,0.0052107268731399845,0.004435146750917017,MPO/PRDX2/SOD1,3,,
GO:0050820,C5,GO:0050820,positive regulation of coagulation,3/65,30/18870,0.00014819175019048552,0.00562348694143895,0.004786470380113742,APOH/F12/PRDX2,3,,
GO:0034614,C5,GO:0034614,cellular response to reactive oxygen species,5/65,154/18870,0.0001888671101333711,0.006983240328521054,0.005943834019312029,CAT/MPO/PRDX2/SOD1/TXN,5,,
GO:0072524,C5,GO:0072524,pyridine-containing compound metabolic process,4/65,85/18870,0.00021056436404625261,0.0075908453238674066,0.006461001275735014,ALDOB/LDHB/PNP/TALDO1,4,,
GO:0034599,C5,GO:0034599,cellular response to oxidative stress,6/65,255/18870,0.0002434256659742061,0.008442595150438156,0.0071859741188487385,CAT/MPO/PPIA/PRDX2/SOD1/TXN,6,,
GO:0044409,C5,GO:0044409,entry into host,5/65,163/18870,0.00024590082962441226,0.008442595150438156,0.0071859741188487385,ANPEP/FCN3/FUCA2/NCAM1/P4HB,5,,
GO:0002474,C5,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,3/65,36/18870,0.00025679680625100254,0.00861165103753362,0.007329867223712826,CALR/HLA-A/PDIA3,3,,
GO:0045104,C5,GO:0045104,intermediate filament cytoskeleton organization,4/65,94/18870,0.00030986270581451756,0.010147708890453378,0.008637293646447651,KRT1/KRT77/KRT9/SOD1,4,,
GO:0045103,C5,GO:0045103,intermediate filament-based process,4/65,95/18870,0.0003226513904098404,0.010147708890453378,0.008637293646447651,KRT1/KRT77/KRT9/SOD1,4,,
GO:1903034,C5,GO:1903034,regulation of response to wounding,5/65,173/18870,0.00032371332105468473,0.010147708890453378,0.008637293646447651,APOH/F12/KRT1/PRDX2/SERPINC1,5,,
GO:1902175,C5,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,3/65,46/18870,0.0005327167892200558,0.016344204469262137,0.013911484350069094,P4HB/PPIA/SOD1,3,,
GO:0030195,C5,GO:0030195,negative regulation of blood coagulation,3/65,48/18870,0.0006040022659591502,0.018145234739856138,0.015444443905885286,APOH/F12/KRT1,3,,
GO:0001867,C5,GO:0001867,"complement activation, lectin pathway",2/65,11/18870,0.0006298444003785649,0.018509999929289533,0.015754916357071026,FCN3/KRT1,2,,
GO:1900047,C5,GO:1900047,negative regulation of hemostasis,3/65,49/18870,0.0006418169184913154,0.018509999929289533,0.015754916357071026,APOH/F12/KRT1,3,,
GO:0016032,C5,GO:0016032,viral process,7/65,432/18870,0.0006961273339639211,0.019682659128940672,0.016753033465468154,ANPEP/CFL1/CSF1R/FCN3/NCAM1/P4HB/PPIA,7,,
GO:0062197,C5,GO:0062197,cellular response to chemical stress,6/65,317/18870,0.0007701398275310958,0.021356569832689232,0.01817779430974206,CAT/MPO/PPIA/PRDX2/SOD1/TXN,6,,
GO:0098761,C5,GO:0098761,cellular response to interleukin-7,2/65,13/18870,0.0008892706845658872,0.02419487409705678,0.020593636905736335,P4HB/PDIA3,2,,
GO:0071675,C5,GO:0071675,regulation of mononuclear cell migration,4/65,125/18870,0.0009092981755908422,0.024281629059296192,0.02066747900075871,CALR/CSF1R/ECM1/MSN,4,,
GO:0052372,C5,GO:0052372,modulation by symbiont of entry into host,3/65,56/18870,0.0009492152877585362,0.024886698999051077,0.02118248852682207,FCN3/FUCA2/P4HB,3,,
GO:0006457,C5,GO:0006457,protein folding,5/65,223/18870,0.0010231552146372498,0.026188216043855767,0.022290283894543995,CALR/HSPA5/P4HB/PDIA3/PPIA,5,,
GO:0098760,C5,GO:0098760,response to interleukin-7,2/65,14/18870,0.0010351791362689172,0.026188216043855767,0.022290283894543995,P4HB/PDIA3,2,,
GO:0031638,C5,GO:0031638,zymogen activation,3/65,59/18870,0.0011050498287972707,0.027473825053890767,0.023384539026817017,APOH/F12/PRSS3,3,,
GO:0030168,C5,GO:0030168,platelet activation,4/65,133/18870,0.0011450611492414369,0.027986070800104273,0.02382054058903685,ADAMTS13/HBB/PDIA3/PPIA,4,,
GO:0015671,C5,GO:0015671,oxygen transport,2/65,15/18870,0.0011917863188835975,0.028642597863835797,0.024379348207338152,HBA1/HBB,2,,
GO:0019755,C5,GO:0019755,one-carbon compound transport,3/65,61/18870,0.0012173962473639177,0.02877844899506179,0.02449497885118771,CA2/HBA1/HBB,3,,
GO:0090303,C5,GO:0090303,positive regulation of wound healing,3/65,62/18870,0.0012761677786087505,0.02968119252828739,0.02526335534563333,APOH/F12/PRDX2,3,,
GO:0008631,C5,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,3/65,63/18870,0.0013366981643775455,0.030149315647599106,0.02566180162427955,P4HB/PPIA/SOD1,3,,
GO:0002679,C5,GO:0002679,respiratory burst involved in defense response,2/65,16/18870,0.0013590190825894187,0.030149315647599106,0.02566180162427955,MPO/PRDX2,2,,
GO:0072378,C5,GO:0072378,"blood coagulation, fibrin clot formation",2/65,16/18870,0.0013590190825894187,0.030149315647599106,0.02566180162427955,APOH/F12,2,,
GO:0043462,C5,GO:0043462,regulation of ATP-dependent activity,3/65,64/18870,0.001399007063242259,0.030566184624171776,0.026016622579592887,ALDOB/PFN1/TPM2,3,,
GO:0043903,C5,GO:0043903,regulation of biological process involved in symbiotic interaction,3/65,65/18870,0.0014631138788608962,0.031489704676379286,0.026802683153995362,FCN3/FUCA2/P4HB,3,,
GO:0016485,C5,GO:0016485,protein processing,5/65,245/18870,0.0015519478303027791,0.032910423107303056,0.028011937618158518,ADAMTS13/APOH/F12/P4HB/PRSS3,5,,
GO:0006089,C5,GO:0006089,lactate metabolic process,2/65,18/18870,0.0017250705701305838,0.03454933002955975,0.029406904748132463,LDHA/LDHB,2,,
GO:0009313,C5,GO:0009313,oligosaccharide catabolic process,2/65,18/18870,0.0017250705701305838,0.03454933002955975,0.029406904748132463,CTBS/MANBA,2,,
GO:0020027,C5,GO:0020027,hemoglobin metabolic process,2/65,18/18870,0.0017250705701305838,0.03454933002955975,0.029406904748132463,CAT/HPX,2,,
GO:0051917,C5,GO:0051917,regulation of fibrinolysis,2/65,18/18870,0.0017250705701305838,0.03454933002955975,0.029406904748132463,APOH/F12,2,,
GO:0048002,C5,GO:0048002,antigen processing and presentation of peptide antigen,3/65,71/18870,0.0018865659583460733,0.03677625213260232,0.03130236512637003,CALR/HLA-A/PDIA3,3,,
GO:0072376,C5,GO:0072376,protein activation cascade,2/65,19/18870,0.001923744805746647,0.03677625213260232,0.03130236512637003,APOH/F12,2,,
GO:0006801,C5,GO:0006801,superoxide metabolic process,3/65,72/18870,0.0019637804536826483,0.03677625213260232,0.03130236512637003,MPO/PRDX2/SOD1,3,,
GO:0050766,C5,GO:0050766,positive regulation of phagocytosis,3/65,72/18870,0.0019637804536826483,0.03677625213260232,0.03130236512637003,CALR/FCN3/SOD1,3,,
GO:0070527,C5,GO:0070527,platelet aggregation,3/65,72/18870,0.0019637804536826483,0.03677625213260232,0.03130236512637003,HBB/PDIA3/PPIA,3,,
GO:0045109,C5,GO:0045109,intermediate filament organization,3/65,73/18870,0.002042939130512308,0.03750528825659921,0.03192288934023993,KRT1/KRT77/KRT9,3,,
GO:0046718,C5,GO:0046718,viral entry into host cell,4/65,156/18870,0.0020570200942777016,0.03750528825659921,0.03192288934023993,ANPEP/FCN3/NCAM1/P4HB,4,,
GO:0002396,C5,GO:0002396,MHC protein complex assembly,2/65,20/18870,0.0021327556428856692,0.03750528825659921,0.03192288934023993,CALR/PDIA3,2,,
GO:0002501,C5,GO:0002501,peptide antigen assembly with MHC protein complex,2/65,20/18870,0.0021327556428856692,0.03750528825659921,0.03192288934023993,CALR/PDIA3,2,,
GO:0006098,C5,GO:0006098,pentose-phosphate shunt,2/65,20/18870,0.0021327556428856692,0.03750528825659921,0.03192288934023993,ALDOB/TALDO1,2,,
GO:0061045,C5,GO:0061045,negative regulation of wound healing,3/65,75/18870,0.002207157545859209,0.03834603832685517,0.03263849966356167,APOH/F12/KRT1,3,,
GO:0044794,C5,GO:0044794,positive regulation by host of viral process,2/65,21/18870,0.002352031733759929,0.03998312003881149,0.03403191325297773,CFL1/CSF1R,2,,
GO:1903036,C5,GO:1903036,positive regulation of response to wounding,3/65,77/18870,0.0023793558741134206,0.03998312003881149,0.03403191325297773,APOH/F12/PRDX2,3,,
GO:0050900,C5,GO:0050900,leukocyte migration,6/65,396/18870,0.002393144277379,0.03998312003881149,0.03403191325297773,CALR/CSF1R/ECM1/MSN/PPIA/SELL,6,,
GO:0016052,C5,GO:0016052,carbohydrate catabolic process,4/65,163/18870,0.0024122964239782245,0.03998312003881149,0.03403191325297773,ALDOB/CTBS/LDHA/MANBA,4,,
GO:0019362,C5,GO:0019362,pyridine nucleotide metabolic process,3/65,79/18870,0.0025596650391539735,0.04136140009407901,0.03520504599583628,ALDOB/LDHB/TALDO1,3,,
GO:0046496,C5,GO:0046496,nicotinamide nucleotide metabolic process,3/65,79/18870,0.0025596650391539735,0.04136140009407901,0.03520504599583628,ALDOB/LDHB/TALDO1,3,,
GO:0061687,C5,GO:0061687,detoxification of inorganic compound,2/65,22/18870,0.0025815020863156108,0.04136140009407901,0.03520504599583628,CAT/TXN,2,,
GO:0006740,C5,GO:0006740,NADPH regeneration,2/65,23/18870,0.002821096062689725,0.044217614373897644,0.03763613282718787,ALDOB/TALDO1,2,,
GO:0043171,C5,GO:0043171,peptide catabolic process,2/65,23/18870,0.002821096062689725,0.044217614373897644,0.03763613282718787,ADAMTS13/ANPEP,2,,
